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ABSTRACT OF THE DISSERTATION 
 
The Selective and Combinatorial Regulation of Toll-Like 
Receptor-Activated Transcriptional Cascades 
 
by 
 
Xin Liu 
Doctor of Philosophy in Molecular Biology 
University of California, Los Angeles, 2017 
Professor Stephen T. Smale, Chair 
 
The immune system is essential for host defense to pathogen infection, tissue repair, 
stress response, and other physiological functions. An unbalanced immune system is 
detrimental to homeostasis and mammalian survival. Immunodeficiency can cause 
susceptibility to pathogen infection. A hyperactive immune system can cause 
autoimmunity and chronic inflammatory diseases including rheumatoid arthritis, 
psoriasis, and atherosclerosis. Deciphering the mechanisms regulating the immune 
response will illuminate on the pathogenesis of inflammatory diseases and promote the 
development of new therapies to treat these diseases. Because innate immunity is the 
first line of host defense and transcription is a critical contributor to the innate immune 
response, we focused our studies on mechanisms regulating transcriptional activation of 
the innate immune response.  
  iii 
Toll-like receptor (TLR) signaling is a classical model to study pathogen recognition and 
the activation of innate immunity. TLR transcriptional cascades have been extensively 
studied using conventional systems approaches. Because conventional systems 
approaches rely on statistics and large sample sizes to uncover the common regulatory 
mechanisms, they often miss gene-specific regulatory mechanisms. To reveal gene-
specific regulatory mechanisms, we used a stringent systems approach to dissect the 
TLR transcriptional cascades in chapter 2. To prevent biases towards the majority of 
weakly induced genes, we separated strongly induced genes from weakly induced 
genes. Combining high-resolution transcriptional profiles and perturbation studies, we 
classified TLR4-activated genes by their activation mechanisms. By integrating RNA-
seq, ChIP-seq, ATAC-seq, and motif data, we found that several key inflammatory genes 
are regulated by highly selective mechanisms. TLR4-activated nuclear factor kappa B 
(NFκB) and interferon regulatory factor 3 (IRF3) selectively regulate a small subset of 
pro-inflammatory genes by chromatin and combinatorial regulation. We also found serum 
response factor (SRF) selectively regulates a few early transient primary response 
genes. In chapter 3, we used a gene-centric method and identified the motif rules 
governing the combinatorial regulation of serum response factor (SRF) and ternary 
complex factor (TCF). Ternary complex formation can enhance SRF binding and 
promote histone mark deposition. The active ternary complex can regulate transcription 
through either promoter or enhancer. Taken together, we demonstrated a gene-centric, 
stringent systems approach that can complement the conventional systems approach to 
unveil gene-specific regulatory mechanisms in ligand-induced transcriptional cascades.  
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CHAPTER 1 
 
 
 
 
 
Introduction 
The Transcriptional Regulation of Innate Immune Response 
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A. Immune Responses   
The immune system is indispensable for vertebrate survival. Immune cells circulate 
throughout the body and participate in a wide variety of roles including tissue 
development and repair, host defense against pathogen infection, and stress response. 
Upon pathogen infection, the immune system can trigger two types of responses: the 
innate immune response and the adaptive immune response. The innate immune 
response typically involves neutrophils, macrophages, and dendritic cells. They express 
pattern recognition receptors that can recognize non-self molecules unique to 
pathogens. Upon on activation, they rapidly produce numerous cytokines and 
chemokines, which in turn recruit other effector cells to sites of inflammation. 
Furthermore, macrophages and dendritic cells can bridge the innate and adaptive 
immunity by presenting antigens to adaptive immune cells. Adaptive immune cells are 
composed of T and B lymphocytes. Adaptive immune cells undergo DNA 
rearrangement to generate pathogen-specific responses. They can also generate 
memory cells that respond quickly upon subsequent encounters to the same pathogen. 
While innate immune cells detect pathogens by pre-programmed systems such as 
pattern recognition receptors, the adaptive immune cells go through DNA arrangement 
that allows for plasticity, selectivity, and memory. But recent discoveries suggest that 
macrophages can also develop trained “memory” to previous stimuli (Netea et al., 2016; 
Ostuni et al., 2013).  
 
Because the immune system is constantly reacting to intrinsic and extrinsic stimuli, it is 
in a dynamic equilibrium and requires proper balance between host defense and 
  3 
homeostasis (Eberl, 2016). Insufficient immune activity can cause immunodeficiency 
and susceptibility to pathogen infection whereas over-activation of the immune system 
can cause allergy, autoimmunity, and chronic inflammatory diseases including 
rheumatoid arthritis, inflammatory bowel disease, and psoriasis (Hato and Dagher, 
2014; Eberl, 2016). Because the immune system is involved in maintaining homeostasis 
in many tissues, its deficiency or over-activation also contribute to the pathogenesis of 
many “modern diseases” including diabetes, Alzheimer’s disease, atherosclerosis, and 
cancer (Kotas and Medzhitov, 2015; Okin and Medzhitov, 2012; Lampron et al., 2013; 
Hansson and Libby, 2006). Demystifying the regulation of the immune system is critical 
to understanding disease pathogenesis and developing novel therapies for 
inflammatory, autoimmune, and other diseases. Because pathogen recognition by 
innate immune cells is the first step of the immune response, understanding the 
regulation of innate immune cell is key to unraveling the immune response cascades.  
 
B. Pattern Recognition Receptors and TLR Signaling  
Innate immune cells can recognize pathogen-associated molecular patterns or danger-
associated molecular patterns by pattern recognition receptors. They can sense non-
self components and initiate the innate immune response, which in turn activates the 
adaptive immune response (Janeway, 1989). They can recognize extracellular and 
intracellular pathogen components such as lipopolysaccharides, lipoprotein, zymosan, 
and pathogenic nucleic acids. To recognize a broad range of pathogen components, 
pattern recognition receptors have diversified into many different receptor families. 
These include Toll-like receptors (TLRs), RIG-I-like receptors (RLRs), nucleotide-binding 
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oligomerization domain, leucine-rich repeat-containing receptors (NLRs), and C-type 
lectin receptors (CLRs) (Iwasaki and Medzhitov, 2015; Thompson et al., 2011). Other 
newly discovered families include AIM2-like receptors, DAI, and cGAS (Bürckstümmer 
et al., 2009; Takaoka et al., 2007; Cai et al., 2014). TLRs are a well-characterized 
founding family of pathogen recognition receptors consisting of 9 members. Depending 
on the location of their ligands, they reside in different cellular compartments. TLR1, 
TLR2, TLR4, TLR5, TLR6, TLR11 (only in mouse) are located on the cell surface 
membrane to detect extracellular pathogen components. For example, TLR4 can 
recognize lipopolysaccharides, mannan, and glycoinositol phospholipids from Gram-
negative bacteria. TLR3, TLR7, TLR8, and TLR9 reside on the membrane of 
endolysosome. They are specialized in sensing intracellular pathogens such as virus 
and mycobacteria. For example, TLR3 can recognize viral RNA; TLR9 can recognize 
viral DNA. RLRs are intracellular sensors of viral RNA (Loo and Gale, 2011). NLRs 
consist of 23 members, located in cytoplasm, plasma membrane, or endosome. They 
detect a diverse range of intracellular pathogen components including bacterial 
peptides, bacterial toxin, and bacterial flagellin (Motta et al., 2015). CLRs reside on the 
cell membrane and detect fungal and bacterial components including glucan, mannan, 
and glycoprotein (Hoving et al., 2014). The redundancy within and between families 
allows them to act in concert to amplify innate immune responses (Kawai and Akira, 
2011).     
  
C. TLR Signaling and Transcriptional Cascades 
Toll-like receptors were discovered 20 years ago, as the first mammalian pattern 
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recognition receptor family (Lemaitre et al., 1996). Although 11 mammalian TLR 
members are activated by different ligands, they share several common signaling 
pathways. TLR4 represents a typical pattern recognition receptor (Figure 1-1). TLR4 is 
located on the plasma membrane to recognize extracellular microorganisms. Its 
extracellular domain contains leucine-rich domains adopting a horseshoe-like structure 
(Kim et al., 2007). With the assistance of other trans-membrane molecules including 
MD2, LPS binding protein, and CD14, TLR4 can recognize and bind to ligands such as 
lipopolysaccharides. This induces TLR4 homo-dimerization and conformation changes 
of the intracellular domain. The intracellular domain belongs to the Toll/IL-1R (TIR) 
domain family, which can induce intracellular signaling. The selectivity of intracellular 
pathways is dependent on the ability to recruit different adaptors. Through TIR domain, 
TLR4 can recruit at least two adaptors: myeloid differentiation primary response gene 
88 (MyD88) and TIR-domain-containing adapter-inducing interferon-β (TRIF).  
 
MyD88-dependent pathways trigger a cascade of signal molecules, leading to the 
activation of the MAPK and NFκB pathways (Figure 1-1). Activated TLR4 can interact 
with TIRAP through homotypic interaction of TIR domains (Akira and Takeda, 2004). 
TIRAP can then recruit MyD88 to membrane TLR4. The activated MyD88 will assemble 
into a signaling complex called myddosome by recruiting IRAKs and TRAF6 (Brubaker 
et al., 2015). Upon Phosphorylation and activation by IRAK4, IRAK1 can phosphorylate 
the E3 ubiquitin ligase TRAF6. Active TRAF6 can induce the polyubiquitination of TAK1 
and the release of TAK1 into the cytosol. TAK1 acts upstream of the MAPK and NFκB 
pathways (Brubaker et al., 2015; O’Neill et al., 2013). TAK1 phosphorylates IKKβ, which 
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induces phosphorylation and proteasome degradation of NFκB inhibitor IκBα. 
Dissociation from IκBα allows NFκB to translocate into the nucleus and activate pro-
inflammatory genes. TAK1 also functions as MAPKKK to activate the MAPK pathway, 
which in turn induces its downstream transcription factors including CREB, AP1, and 
SRF. These transcription factors also contribute to the induction of many early and late 
inflammatory genes. Because MyD88-dependent signaling starts at the plasma 
membrane and does not require receptor internalization, it can rapidly induce gene 
transcription, generating an early wave of TLR4-activated transcription (Warner and 
Núñez, 2013).  
 
Another TLR4 signaling pathway, TRIF-dependent pathway, follows the internalization of 
TLR4 and induces the NFκB and IRF pathways, leading to a late wave of transcriptional 
activation. Although its regulation is still unclear, CD14 can mediate activated TLR4 
trafficking from plasma membrane to endosome through the ITAM pathway. After 
internalization to the endosome membrane, TLR4 can interact with the sorting adaptor 
TRAM and recruit TRIF. Similar to MyD88, TRIF can assemble a signaling complex, 
which recruits RIPK1, TRADD, caspase-8 complex, and IKKs. Activated IKKs trigger 
NFκB signaling, thus promoting sustained NFκB activation following MyD88-activated 
NFκB signaling. TRIF also recruits TRAF3, TANK, TBK1, IKKγ, and IKKε. TBK1 and 
IKKs phosphorylate and activate IRF3, which can translocate into the nucleus and 
induce type I IFN production (Yamamoto and Takeda, 2010; Brubaker et al., 2015; 
Yamamoto and Takeda, 2010).   
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Intriguingly, TLR4 signaling pathways also induce negative regulators that inhibit TLR4 
signaling at multiple stages including the signaling, transcriptional, and post-
transcriptional stages. For example, TLR4 signaling can strongly induce genes 
encoding the negative regulators of the NFκB pathway such as A20. A20 can inhibit 
NFκB pathway by several mechanisms. It can remove the K63 ubiquitination from 
TRAF6 or inhibit TRAF6 E3 ligase activity, thus preventing NFκB activation through the 
MyD88 pathway (Boone et al., 2004; Shembade et al., 2010). It can also inhibit TRAF3 
interaction with TBK1 and IKKs, thus preventing NFκB activation through the TRIF 
pathway (Parvatiyar et al., 2010). TLR4 signaling also rapidly induces transcription of 
ATF3, which can recruit HDACs and restrict chromatin accessibility to prevent 
transcriptional induction (Gilchrist et al., 2006; Whitmore et al., 2007). Lastly, TLR4 
signaling also strongly induces TTP (also known as ZFP36 or TIS11), an RNA-binding 
protein. By inducing transcription and phosphorylation, TTP can bind to the AU-rich 
elements in the 3’-UTR of many pro-inflammatory mRNAs and mediate their 
degradation (Deleault et al., 2008; Lai et al., 2006). Recent studies also found that TLR4 
signaling can produce anti-inflammatory fatty acids, which contribute to inflammation 
resolution (Oishi et al., 2017). Thus, TLR4 signaling can robustly induce two waves of 
pro-inflammatory and IFN gene induction, subject to auto-regulatory negative feedback 
mechanisms.  
 
D. The Contribution of Transcription to TLR4 Activation 
Besides transcriptional activation, TLR4 signaling also triggers many changes at the 
levels of mRNA splicing, mRNA degradation, translation, and protein degradation 
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(Vogel and Marcotte, 2012). Therefore, the rate of protein accumulation is 
disproportionate to the rate of transcription. For example, because TLR4 signaling can 
also activate factors controlling translation, some genes appear weakly or barely 
inducible by transcription, but their protein levels exhibit significant increase. Because 
TLR4 signaling also induces factors controlling mRNA degradation or protein 
degradation, some genes appear unaffected by transcription but show reduced protein 
abundance (Rabani et al., 2014; Jovanovic et al., 2015). Splicing rates of nascent 
transcripts can also affect protein abundance (Jovanovic et al., 2015; Bhatt et al., 2012). 
Because of the technical limitations of microarray and un-labeled mass spectrometry, 
the contribution of transcription in cellular response was underestimated. With the 
emergence of RNA-seq, biochemical labeling methods, and improved mass 
spectrometry, several studies revealed that transcription is the major contributor to 
cellular responses in both mouse and human (Li and Biggin, 2015; Vogel et al., 2010; 
Vogel and Marcotte, 2012). Transcription has a huge impact on protein expression. In 
yeast, every mRNA molecule can produce approximately 5000 protein molecules (Lu et 
al., 2007). In TLR signaling, mRNA can explain 90% of the changes in protein level, 
while translation and protein degradation only explain 10% of the changes (Jovanovic et 
al., 2015). Acting as the upstream of protein synthesis, transcription is also associated 
with most of phenotypic variance (Battle et al., 2015). Because transcription can 
significantly affect the output of stimulus-induced responses, we will focus our studies 
on the transcriptional regulatory mechanisms in macrophages. 
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E. Primary and Secondary Response Genes Induced by TLR4 Signaling 
Ligand-induced transcriptional cascades are universal in eukaryotic cells. By their 
activation mechanisms, ligand-induced genes can be roughly divided into primary and 
secondary response genes (K R Yamamoto and Alberts, 1976; Herschman, 1991). 
Activation of primary response genes depends on existing signaling molecules and is 
independent of new protein synthesis. They are immediately downstream of receptor-
induced signaling through post-translational modifications or nuclear translocation of 
transcription factors. Therefore, primary response genes are often rapidly induced. In 
contrast, activation of secondary response genes requires new protein synthesis, which 
results in delayed transcriptional induction.  
 
Besides their differences in transcriptional kinetics and regulatory mechanisms, primary 
and secondary response genes also have other distinct characteristics. Many primary 
response genes possess CpG-island promoters that are constitutively accessible 
(Ramirez-Carrozzi et al., 2009). Their promoters also associated with active histone 
marks including H3K4me3, H3S10ph, and histone acetylation (Fowler et al., 2011). 
Their promoters also have paused RNA Pol II with serine 5-phospohrylation, which can 
quickly transition into active elongation upon stimulus-induced P-TEFb recruitment 
(Hargreaves et al., 2009; Medzhitov and Horng, 2009). Many primary response genes 
are relatively small genes that contain fewer exons than secondary response genes, 
leading to rapid transcriptional and splicing rates (Tullai et al., 2007). In contrast, 
secondary response genes often lack CpG-island promoters and require stimulus-
induced transcription factors that can recruit chromatin remodeling complex to initiate 
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chromatin remodeling (Ramirez-Carrozzi et al., 2009; Ramirez-Carrozzi et al., 2006). 
Besides mechanistic differences, primary response genes and secondary response 
genes also differ in their biological functions. In TLR4 signaling, many primary response 
genes encode signaling molecules, transcription factors, and effector molecules. 
Secondary response genes often encode molecules regulating more specific biological 
functions such as antigen presentation and T cell activation (Tong et al., 2016).  
 
Primary and secondary response genes can be interdependent. Primary response 
genes can also encode activators of secondary response genes. For instance, LPS can 
activate the MAPK pathway and induce the primary response genes Fos, Jun, and Atf3, 
which encode AP1/ATF transcription factors (Tong et al., 2016; Bhatt et al., 2012). 
AP1/ATF transcription factors can potentiate the expression of several secondary 
response genes. LPS can also induce primary response gene Ifnb1, which encodes 
type I interferon. Type I interferon is a key immune-regulatory molecule that induces at 
least half of the secondary response genes regulating the interferon response (Raza et 
al., 2014; Amit et al., 2009).   
 
However, the boundary between primary and secondary response genes is often 
blurred. Some genes can behave like both primary and secondary response genes. For 
example, Gbp5 contains a canonical IRF binding site. In early TLR4 signaling, it is a 
primary response gene directly activated by IRF3. Later in TLR4 signaling, it can be 
activated as a secondary response gene by interferon-induced IRF9-STAT1-STAT2 
complex (Ourthiague et al., 2015; Krapp et al., 2016). Limited by the cell-specific 
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expression of key regulators, one gene can be either primary or secondary response 
gene in different cell contexts. For instance, Il6 is a primary response gene induced by 
LPS in macrophages (Ramirez-Carrozzi et al., 2009). But Il6 is a secondary response 
gene in fibroblasts, which is sensitive to cycloheximide, an inhibitor of translation. As an 
initial clue to transcriptional regulatory mechanisms, separating primary and secondary 
response genes is often the first step of gene classification. 
 
F. Selective Regulation of Transcriptional Cascades in Inflammation   
Almost all cells in their native environment are constantly encountering extracellular and 
intracellular stimuli. How cells react to these stimuli depends on cell context and the 
nature of stimuli (Figure 1-2). It is believed that the lineage-determining factors and 
stimulus-regulated transcription factors together shape the transcriptional networks in 
macrophages (Glass and Natoli, 2016; Ostuni and Natoli, 2013; Heinz et al., 2010). 
During cellular development, the environmental cues will elicit the expression of lineage-
determining transcription factors. Some of these factors can act as pioneer factors, 
which can recruit chromatin-remodeling complexes, bind extensively to many cell-
specific cis-regulatory regions, and activate key regulators to promote lineage 
commitment. Subsequent environmental factors can further shape cell identity by 
inducing polarizing factors, which can further differentiate precursor cells into certain cell 
types. By opening chromatin or modifying other chromatin features, both pioneer factors 
and polarizing factors can establish cell-specific cis-regulatory elements including 
enhancers and promoters. Once the mature cells enter peripheral tissues, peripheral 
signals can activate stimulus-specific effector transcription factors, which can bind to 
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cell-specific cis-regulatory elements established during development. Different 
combinations of effector transcription factors can activate unique sets of genes for 
stimulus-specific responses. Deciphering these selective regulation mechanisms is 
essential for understanding the logic of selective gene regulation and developing cell-
specific or gene-specific therapeutics.  
  
G. Cell-Specific Regulation of Transcription  
Cell identity is continually evolving in changing microenvironments. In bone marrow, 
hematopoietic stem cells can differentiate into macrophages in the presence of many 
differentiating factors including colony-stimulating factors, chemokines, morphogens, 
and contact signals (Ostuni and Natoli, 2013; Sánchez-Martín et al., 2011; Amit et al., 
2016). In the presence of tissue-specific factors, tissue-resident macrophages will 
undergo transcriptional and phenotypic changes to adapt to the local microenvironment. 
For example, peritoneal retinoic acids drive unique expression signatures of the 
peritoneal macrophages; brain TGFβ induces genes regulating microglia-specific 
functions (Gosselin et al., 2014; Amit et al., 2016). Besides tissue-specific phenotypes, 
cytokines can prime and polarize macrophages into M1 and M2 macrophages (Martinez 
and Gordon, 2014; Benoit et al., 2008; Mantovani and Locati, 2009). IFNγ can polarize 
macrophages into M1 type macrophages. M1 macrophages are pro-inflammatory, 
typically expressing genes regulating antibacterial functions such as Nos2. On the other 
hand, IL-4 can polarize macrophages into M2 type macrophages. M2 macrophages are 
anti-inflammatory, expressing genes regulating tissue repair such as Arg1. Besides 
transcriptional control, environmental factors also employ epigenetic strategies to shape 
  13 
cell identities.  
 
DNA methylation. DNA methylation is an epigenetic modification that can regulate 
gene transcription. In vertebrates, DNA methylation usually occurs at the cytosine of 
CpG dinucleotide except CpG islands at the promoter. Alteration of DNA methylation by 
developmental and environmental stimuli can cause changes in gene expression and 
cellular functions (Philibert et al., 2012). During blood formation, methylome changes 
are correlated with lineage-specific gene expression and lineage commitment 
(Rönnerblad et al., 2014; Reinius et al., 2012). Knockout of DNA methyltransferase 1 
impaired lineage development (Bröske et al., 2009). Loss of DNA methylation often 
prevents heterochromatin formation, leading to the chromatin accessibility, binding of 
key transcription factors, and marking of active histone. During macrophage 
differentiation, DNA de-methylation promotes the activation of macrophage-specific cis-
regulatory elements and expression of macrophage-specific genes (Wallner et al., 
2016). DNA methylation also plays a role in shaping cell identity by environmental 
signals. For example, DNA methylation participates in M1/M2 macrophage polarization. 
In M1 macrophages, pro-inflammatory genes have hypo-methylated promoters, and 
anti-inflammatory genes have hyper-methylated promoters. This methylation pattern is 
correlated with the skewed expression of pro-inflammatory genes in M1 macrophages. 
M2 macrophages show the opposite methylation and expression patterns at the 
promoters of pro-inflammatory and anti-inflammatory genes (Babu et al., 2015). Thus, 
DNA methylation can refine cell identity by altering the chromatin features and gene 
expression during development and environmental stimulation.  
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Pioneer factors and polarizing factors. Pioneer factors often refer to transcription 
factors that can bind to closed chromatin and modify chromatin features during 
development. Pioneer factor binding and the consequent chromatin changes can 
facilitate or repress the binding of other transcription factors at key cis-regulatory 
elements, leading to transcriptional and phenotypic changes. For example, during 
hematopoiesis, progenitor cells undergo significant changes in transcription factor 
binding, chromatin features, and gene expression (Kowalczyk et al., 2015; Lara-Astiaso 
et al., 2014). Pioneer factors play a pivotal role in maintaining cell identity through 
chromatin regulation. In macrophages and B cells, PU.1 functions as a pioneer factor 
binding to thousands of genomic sites regulating cell-specific gene expression (Ghisletti 
et al., 2010). PU.1 can prevent heterochromatin formation and maintain open chromatin 
by interacting with p300/CBP (Nerlov and Graf, 1998; Yamamoto et al., 1999; Tagore et 
al., 2015). PU.1 can establish de novo enhancers with H3K4me1 and H3K27ac marks. 
Some of these enhancers are constitutively active by directly regulating macrophage-
specific genes; some enhancers are inducible by recruiting other stimulus-induced 
transcription factors such as NFκB, AP1, and IRF. PU.1 can also collaborate with other 
stimulus-induced factors and induce transcriptional and phenotypic changes to adapt to 
the local environment. For example, in peritoneal macrophages, PU.1 can collaborate 
with GATA-6, a transcription factor induced by retinoic acids in the peritoneal cavity, and 
promote the expression of genes regulating gut IgA production (Glass and Natoli, 2016; 
Rosas et al., 2014; Gautier et al., 2014). Besides pioneer factors expressed during 
development, polarizing factors can also regulate gene expression through modifying 
chromatin features at cis-regulatory elements. Polarizing factors are often transcription 
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factors that are induced by microenvironment signals. In M2 macrophage polarization, 
IL-4-induced STAT6 can activate the H3K27 demethylase Jmjd3. Jmjd3 removes 
H3K27me2/3 marks on inactive cis-regulatory elements and promotes the expression of 
M2 marker genes (Ishii et al., 2009). Thus, by establishing novel cis-regulatory 
elements, both pioneer factors and polarizing factors can shape cell identity by acting 
alone or collaborating with other stimulus-induced transcription factors.  
 
H. Stimulus-Specific Regulation of Transcription  
Environmental stimuli can activate different receptors to promote stimulus-specific 
cellular responses. The activated receptors use different combinations of signaling 
molecules and transcription factors to induce genes regulating stimulus-specific 
responses. For example, different TLRs selectively activated anti-bacterial or anti-viral 
genes by using different adaptors and downstream signaling molecules. The membrane 
receptors TLR1, TLR2, TLR5, and TLR6 use adaptors MyD88 to activate the MAPK and 
NFκB pathways, inducing pro-inflammatory genes encoding cytokines, chemokines, and 
anti-bacterial peptides. The intracellular receptor TLR3 uses TRIF to activate the NFκB 
and IRF pathways, inducing pro-inflammatory genes and type I interferon response 
genes. TLR4 uses both MyD88 and TRIF adaptors to activate pro-inflammatory and 
type I interferon response genes. However, the limited number of transcription factors 
cannot fully explain the differential expression induced by different stimuli. While there 
are around 30,000 genes in the mouse genome, there are fewer than 3,000 
transcription factors. Therefore, cells might leverage the limited number of transcription 
factors for selective gene activation using other strategies. These strategies are often 
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prevalent for regulating important transcription factors and important genes.  
 
In TLR signaling, some key transcription factors can undergo multiple post-translational 
modifications that affect their activity and stability. One example is IRF3. It can induce 
type I IFN production in activated macrophages. Depending on the specific stimuli, IRF3 
can have at least three different types of post-translational modifications. In TLR4 
signaling, TBK1 or IKKε can phosphorylate IRF3 C-terminal Ser/Thr clusters. IRF3 
phosphorylation increases the negative charges and induces structural changes. This 
leads to IRF3 dimerization, nuclear translocation, DNA binding, and interaction with 
coactivators CBP/p300 (Panne et al., 2007; Dragan et al., 2007). IRF3 activity is also 
negatively regulated by SUMOylation at Lys152. Mutation of the SUMUylation site or the 
SUMO-conjugating enzyme UBC9, enhances transcriptional activity of IRF3 and 
elevates type I interferon production (Kubota et al., 2008; Decque et al., 2015). 
Additionally, IRF3 stability is regulated by polyubiquitination. Pin1 can bind to 
phosphorylated IRF3 and promote IRF3 degradation by proteasomes, resulting in a 
transient expression of type I IFN (Saitoh et al., 2006; Lin et al., 1998). On the other 
hand, HERC5 can prevent Pin1 binding and stabilize IRF3 by coupling ISG15 to IRF3, 
which results in a sustained expression of type I interfereon and robust antiviral 
response (Shi et al., 2010). Therefore, by carefully balancing different post-translational 
modifications of IRF3, cells can precisely regulate the temporal expression of type I 
interferon and anti-viral response genes.  
 
Besides regulating key transcription factors, selective regulatory mechanisms also 
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include the combinatorial interaction of transcription factors. Combinatorial regulation is 
widely used to regulate diverse biological functions including immune responses, cell 
proliferation and differentiation, and vascular development. One typical example of 
combinatorial regulation involves the transcription factor SRF. Although SRF is widely 
expressed, it can selectively induce transcription by interacting with two different 
cofactors: TCF transcription factors and MRTF transcription factors. Upon MAPK 
activation, SRF can partner with TCF to rapidly activate many primary response genes 
including c-fos, Egr1, and Nr4a1 (Treisman et al., 1992; Gregg and Fraizer, 2011; 
Costello et al., 2004). SRF and TCF motifs have short and flexible spacing (Treisman et 
al., 1992; Posern and Treisman, 2006). At the promoter of c-fos, TCF binds to an Ets 
motif with a short core motif GGA; SRF binds to a core motif CCATATTAGG. The 
distance between Ets motif and SRF motif on c-fos promoter is only 3bp, thus allowing 
SRF to form a ternary complex with TCF (Mo et al., 2001). The cooperative binding of 
SRF and TCF stabilizes the binding of both factors on DNA (Kukushkin et al., 2002; 
Treisman et al., 1992). The binding of the complex causes a stronger bending of DNA 
towards SRF than SRF binding alone (Hassler, 2001). This probably allows SRF to 
make more extensive contact with DNA in the ternary complex than SRF binding alone. 
Both SRF and TCF are required for transcriptional activation. Mutation of either site will 
abolish gene induction. Another SRF cofactor, MRTF, can compete with TCF for the 
same binding domain on SRF (Murai and Treisman, 2002; Wang et al., 2004). Unlike 
TCF, MRTF does not bind to DNA in a sequence-specific manner. It indirectly binds to 
SRF motif through SRF recruitment.  
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IFNB1, encoding type I interferon in human, is a primary response gene induced by 
TLR4 signaling. It is also an autocrine molecule that triggers half of the secondary 
response genes, which regulate the interferon response and antiviral response. IFNB1 
transcription relies on the cooperative binding of three different transcription factors: 
ATF-2/c-Jun, IRF3/IRF7, and NFκB. Their binding sites on IFNB1 promoter comprise a 
tightly packed 55-bp motif including one AP1 site, two IRF sites, and one NFκB site. 
This motif is highly conserved in mammals, suggesting that they are functionally 
important. Although these transcription factors lack physical contact in crystal structure, 
they can bind cooperatively to the promoter and form a large functional complex called 
the enhanceosome (Panne et al., 2007; Thanos et al., 1993). The formation of the 
enhanceosome requires the architectural protein HMGI(Y) and the orderly recruitment 
of  histone acetylase, chromatin remodeling complexes, and transcription initiation 
machinery (Agalioti et al., 2000; Merika et al., 1998). In embryonic stem cells, Oct4 and 
Sox2 transcription factors can also bind cooperatively to a composite site and regulate 
genes essential for maintaining pluripotency (Reményi et al., 2004). In antigen-
presenting cells, CIITA complexes with RFX, X2BP, and NF-Y transcription factors, 
acting as a master control factor of MHCII genes (Ludigs et al., 2015; LeibundGut-
Landmann et al., 2004). In endothelial cells, Forkhead and Ets transcription factors bind 
cooperatively to a highly conserved Ets:Fox motif composite and selectively activate 
genes regulating vascular development (Val et al., 2008).  
 
Combinatorial regulation requires fulfilling rules in motif, dimerization, and post-
translational modification. In combinatorial regulation, transcription factors often need 
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strong motifs for binding, but their motifs may also diverge slightly from the canonical 
motifs for optimal protein interaction. And because the cooperative binding may stabilize 
protein binding in the complex, transcription factors can sometimes bind to weak motifs. 
For example, ternary complex formation allows TCF binding to a suboptimal Ets site 
near SRF site (Treisman et al., 1992). Short motif spacing is often required for physical 
interaction between transcription factors. Some have strict motif spacing, but some have 
flexible spacing. For example, the cooperative binding of Forkhead factor and Ets factor 
requires no spacing between the two motifs (Val et al., 2008). In contrast, TCF interacts 
with SRF through a flexible linking domain and forms a complex with SRF with variable 
spacing (Treisman et al., 1992). Besides motif requirements, combinatorial regulation 
might also prefer selective dimers. For example, the AP1 site on human IFNB1 
enhanceosome prefers the AP1 dimer formed by c-Jun and ATF2. A selective dimer 
further ensures the precise of transcriptional activation by selective stimuli. Lastly, 
combinatorial regulation can also depend on selective translational modifications of 
transcription factors. For example, SRF and TCF can form a ternary complex on DNA 
prior to stimulation, but the complex is not activated until TCF phosphorylation by MAPK 
(Herrera et al., 1989; Gineitis and Treisman, 2001).  
 
In eukaryotic cells, DNA wraps around histone proteins and assembles into a unit called 
a nucleosome. Each nucleosome is composed of 146bp DNA wrapped around an 
octamer consists of two copies each of H2A, H2B, H3, and H4. Between neighboring 
nucleosomes, there is usually a 10-50bp linker DNA bound by histone H1. To pack 3 
billion base pairs of human genome into 2nm fibers, nucleosomes also fold into higher 
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order of structures (Woodcock and Ghosh, 2010; Luger et al., 2012). Because many 
cis-regulatory elements are buried in the nucleosome structure, protein binding to these 
inaccessible sites requires chromatin-remodeling complexes such as SWI/SNF. They 
can open chromatin by sliding or removing nucleosomes (Venkatesh and Workman, 
2015; Clapier and Cairns, 2009). Histone modifiers can covalently modify the histone 
residues and alter chromatin structure by changing the electric charges of key residues 
or recruiting other histone regulators (Venkatesh and Workman, 2015; Bannister and 
Kouzarides, 2011). These chromatin regulation strategies increase the complexity of 
selective transcriptional regulation.  
 
Chromatin accessibility is largely affected by the intrinsic properties of promoters. About 
70% of mammalian promoters contain CpG islands (Saxonov et al., 2006). Because 
CpG-island promoters are too rigid to form stable nucleosomes, they are more likely to 
be nucleosome-free and accessible to protein binding (Ramirez-Carrozzi et al., 2009; 
Tazi and Bird, 1990; Choi, 2010). Thus, high CpG content is often sufficient to maintain 
open chromatin at promoters. Because they do not require chromatin remodeling, these 
CpG-island promoters are frequently associated with ubiquitously expressed genes. 
Almost all housekeeping genes possess CpG-island promoters (Zhu et al., 2008). CpG-
island promoters often contain the active promoter mark H3K4me3 and a paused Pol II, 
which is often associated with high basal expression (Hargreaves et al., 2009). 
Conversely, low CpG-island promoters are more likely to form stable nucleosomes, thus 
preventing transcription factor binding and gene activation. Low CpG-island promoters 
often rely on pioneer factors or stimulus-induced factors to recruit chromatin-remodeling 
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complexes and histone modifiers. For example, interferon-γ can synergize with TLR 
agonists to activate pro-inflammatory genes by inducing the transcription factors STAT1 
and IRF1. STAT1 and IRF1 recruit remodeling complexes to low CpG-island promoters, 
resulting in TLR-activated transcription factors binding to accessible promoters and 
transcriptional activation (Qiao et al., 2013; Pattenden et al., 2002). Because low CpG-
island promoters require chromatin remodeling, they often have delayed transcriptional 
activation. 
 
In TLR signaling, chromatin regulation also plays a role in separating primary and 
secondary response genes regulating different biological functions. Many primary 
response genes containing CpG-island promoters encode transcription factors and 
effector molecules. Because they do not require chromatin remodeling, they can be 
quickly induced to activate secondary response genes or auto-regulate primary 
response genes. Conversely, many secondary response genes encode cytokines 
regulating adaptive immune functions. They possess low CpG-island promoters that 
require chromatin remodeling, leading to delayed transcriptional induction (Ramirez-
Carrozzi et al., 2009).  
 
Cell-specific and stimulus-specific regulatory mechanisms often act collaboratively to 
regulate key inflammatory genes. One example is the Il12b gene. It encodes IL-12p40, 
a subunit shared by IL-12 and IL-23. IL-12p40 can dimerize with the constitutively 
expressed IL-12p35 subunit to form IL-12, a cytokine that bridges the innate and 
adaptive immunity by promoting Th1 cell development (Trinchieri, 2003; Trinchieri, 
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1995). IL-12p40 can also dimerize with IL-23p19 to form IL-23, a cytokine essential for 
Th17 development (Vignali and Kuchroo, 2012; Teng et al., 2015). Il12b is inducible by 
cytokine and pattern recognition receptor agonists only in myeloid cells. During 
hematopoiesis, PU.1 binds to the Ets site of Il12b enhancer and maintains an 
accessible enhancer. In cells lacking PU.1, polycomb repressive complex 2 binds to the 
Il12b enhancer and establishes heterochromatin with the repressive histone mark 
H3K27me3 (Tagore et al., 2015). The PU.1-established enhancer ensures the cell-
specific expression of Il12b. Il12b gene transcription requires activation of both the 
promoter and the enhancer. Upon on LPS stimulation, Oct proteins and CEBPβ bind to 
the Il12b enhancer to induce Il12b transcription (Zhou et al., 2007; Bradley et al., 2003). 
Il12b enhancer activity is also negatively regulated by IL-10-induced NFIL3 (Smith et al., 
2011). IRF5 can facilitate the synergy between the Il12b enhancer and promoter by 
binding to the IRF sites on both the enhancer and the promoter of Il12b (Koshiba et al., 
2013). These transcription factors have differential roles in regulating Il12b transcription. 
While CEBPβ mutation does not strongly affect Il12b induction, Oct and IRF5 mutation 
severely impaire Il12b induction (Takaoka et al., 2005; Zhou et al., 2007; Bradley et al., 
2003). The Il12b promoter has binding sites for CEBP, AP1, and NFκB. Among them, 
the NFκB site is most critical for the transcriptional induction of Il12b. The non-canonical 
NFκB site at the Il12b promoter has much a stronger preference for c-Rel:p50 dimer 
than other NFκB dimers. Mutating c-Rel abolished the expression of Il12b, but RelA 
mutation hardly affected Il12b expression (Sanjabi et al., 2005). While the Il12b 
enhancer is constitutively open, Il12b promoter lacks CpG islands and requires TLR-
activated chromatin remodeling for transcriptional activation (Weinmann et al., 2001; 
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Weinmann et al., 1999). However, only about 20% of the macrophages undergo 
chromatin remodeling at promoters after LPS stimulation (Gjidoda et al., 2014). This 
suggests that nucleosomes might compete with transcription factors for DNA binding. 
Interestingly, although c-Rel knockout cells have diminished Il12b induction, it does not 
affect promoter chromatin remodeling (Weinmann et al., 2001). This indicates that c-Rel 
binding is a downstream event of chromatin remodeling. Although there might be other 
as-yet-unknown mechanisms regulating Il12b, Il12b represents a complicated selective 
regulation model combining cell-specific and stimulus-specific mechanisms, which 
involves transcription factor regulation, chromatin regulation, and promoter-enhancer 
interaction.  
 
Cell-specific and stimulus-specific regulation can be interdependent and can share 
similar mechanisms. Pioneer factors can collaborate with stimulus-induced transcription 
factors at cell-specific cis-regulatory elements to activate transcription; and stimulus-
induced factors can also change chromatin status and further shape cell identity. For 
example, differentiated macrophages maintain a certain degree of plasticity. Upon 
repeated bacterial infection, macrophages can develop trained immunity or immune 
tolerance (Netea et al., 2016; Ifrim et al., 2014). LPS-activated transcription factors can 
bind to intergenic sites lacking enhancer marks and establish de novo enhancers by 
promoting the removal of repressive histone marks and the deposition of H3K4me1 
marks (Ostuni et al., 2013; Yoshida et al., 2015). These de novo enhancers are also 
called latent enhancers. Upon the second LPS challenge, they can induce transcription 
more robustly and rapidly than the first challenge. Thus, macrophages are able to gain 
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partial short-term memory to certain environmental stimuli. On the other hand, repeated 
LPS stimulation can also cause weaker or no response, a phenomenon called LPS 
tolerance. LPS can reduce histone acetylation at cis-regulatory elements of some 
induced genes, leading to the non-response or tolerance to the subsequent LPS 
stimulation (Hargreaves et al., 2009). Trained immunity and immune tolerance 
demonstrate that stimulus-specific changes can also shape cell identity and overlap with 
the functions of cell-specific regulatory mechanisms.  
 
I. Selective Regulation of NFκB 
NFκB transcription factors play a pivotal role in innate and adaptive immunity. They are 
widely expressed in many cell types and can be activated by a diverse range of stimuli. 
Dysregulation of NFκB transcription factors is associated with many chronicle 
inflammatory diseases and other diseases including cancer, Alzheimer’s disease, 
diabetes, and atherosclerosis (Hoesel and Schmid, 2013; Patel and Santani, 2009; 
Pamukcu et al., 2011).  
 
NFκB family transcription factors consist of five members: Rel A, RelB, c-Rel, p50, and 
p52. Structurally, all NFκB members share a Rel homology domain (RHD), which is 
responsible for interaction with IκB inhibitor proteins, dimerization, nuclear localization, 
and DNA binding (Hoesel and Schmid, 2013; Lawrence, 2009; Zhang et al., 2017). 
While Rel A, RelB, and c-Rel share an additional transcriptional activation domain, p50 
and p52 precursors share many copies of ankyrin repeats in their C-terminal domains. 
These sequences are responsible for self-inhibition. Because p50 and p52 lack 
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transcription activation domains, their homodimers can bind to NFκB sites as dominant 
negative proteins to inhibit transcription of NFκB targets. NFκB members can form 15 
dimeric species that can bind to DNA. The most important dimers in the immune 
response are RelA:p50, c-Rel:p50, and RelB:p52. NFκB dimers can bind to a 
consensus κB motif: 5′-GGGRN(Y)YYCC-3′ (Hoffmann and Baltimore, 2006). However, 
different dimers favor slightly different κB motifs (Wang et al., 2012). Protein binding 
microarrays reveal three classes of consensus κB motifs. RelA and c-Rel homodimers 
prefer binding to a 9-bp motif; heterodimers prefer binding to a 10-bp motif; and p50 and 
p52 homodimers prefer binding to an 11-bp or a 12-bp motif (Siggers et al., 2012). The 
differential binding of dimers represents one of the strategies to selectively regulate 
NFκB targets. For example, the Il12b promoter has a non-canonical NFκB site that 
favors c-Rel:p50 binding. While Il12b induction was abolished by c-Rel mutation, it was 
not affected by the mutation of other NFκB members (Sanjabi et al., 2005; Tong et al., 
2016).  
 
NFκB transcription factors are regulated by the canonical and non-canonical pathways. 
In the canonical pathway, NFκB is sequestered in the cytoplasm by inhibitory IκB 
proteins including IκBα, IκBβ, IκBγ, and IκBε. IκB proteins mask the nuclear 
translocation signals of NFκB and thereby prevent nuclear translocation. Extracellular 
stimuli like pathogen components and cytokines can activate the IKK complex, which 
consists of IKKα, IKKβ, and regulatory subunit IKKγ. The active IKKβ can phosphorylate 
IκB proteins, inducing IκB protein ubiquitination and proteasome degradation. The 
degradation of IκB proteins releases NFκB, allowing it to dimerize, translocate into 
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nucleus, and bind to NFκB sites regulating pro-inflammatory genes (Shih et al., 2011; 
Hayden and Ghosh, 2012). In the non-canonical pathway, p52 precursor, p100, remains 
in the cytoplasm because of self-inhibitory sequences at the C-terminus. TNF family 
cytokines such as CD40L, BAFF, and RANKL, can activate a complex composed of NIK 
and IKKα. Activated IKKα can phosphorylate p100 and induce removal of these 
inhibitory sequences. The processed p100 releases p52, which can dimerize with RelB 
and translocate into the nucleus (Sun, 2011; Cildir et al., 2016). While the canonical 
pathway activates genes regulating host response to pathogen infection, the non-
canonical pathway often controls genes regulating lymph-organogenesis, B cell 
maturation, and bone metabolism.  
 
NFκB transcription factors are regulated at many steps of gene expression including 
transcription and post-translational modification steps. NFκB members and IκB proteins 
can induce their own transcription in an auto-regulatory manner (Tong et al., 2016). The 
rapid induction of IκB proteins can export nuclear NFκB to the cytoplasm and replenish 
the cytoplasmic pool of NFκB proteins. This results in the transient expression of NFκB 
targets, but it also ensures robust cellular response to repeated stimuli (Kearns et al., 
2006; Nelson et al., 2004; Kellogg and Tay, 2015). NFκB proteins also undergo different 
post-translational modifications that positively or negatively regulate NFκB activity. For 
example, RelA Ser-276 can be phosphorylated by the cytoplasmic protein kinase A or 
the nuclear MSK1. Ser-276 phosphorylation can prevent the folding of two terminal 
domains and facilitate the interaction with the co-activator p300/CBP (Perkins, 2006; 
Zhong et al., 2002). Phosphorylation of Thr-254 of RelA is required for the binding of 
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Pin1, which can activate RelA by promoting RelA dissociation from IκBα. RelA can also 
be acetylated by p300/CBP at multiple sites including Lys-281, Lys-221, and Lys-310. 
While Lys-281 and Lys-221 prevent nuclear IκBα from exporting of RelA, Lys-310 
enhances the transcriptional activity of RelA (Chen et al., 2002). Post-translational 
modifications can also negatively regulate RelA. For example, RelA methylation by Set9 
or ubiquitination by SOCS-1 can result in proteasome-mediated protein degradation and 
termination of transcription (Yang et al., 2009; Ryo et al., 2003; Huang et al., 2010). 
Thus, by combining post-translational modifications and interactions with co-factors, 
NFκB can both broadly and selectively regulate hundreds of pro-inflammatory genes.  
 
J. Serum Response Factor (SRF) and Combinatorial Regulation  
Serum response factor (SRF) is a ubiquitously expressed transcription factor that 
regulates a wide variety of biological functions including cell proliferation and 
differentiation, circadian rhythm, cytoskeleton, cell migration, muscle cell development, 
and inflammation (Olson and Nordheim, 2010; Posern and Treisman, 2006; Knöll and 
Nordheim, 2009). SRF mutation is embryonic lethal during gastrulation. Tissue-specific 
deletion of SRF also causes defects in vascular development, skeletal muscle 
development, neuronal development, B cell and T cell maturation, and macrophage 
functions (Miano, 2010). It is interesting that such a ubiquitously expressed transcription 
factor can selectively regulate genes involved in diverse functions in different cell types.  
 
SRF belongs to the MADS domain protein family that is conserved from yeast to human. 
It binds to DNA as a homodimer and induces a 72° bending of DNA towards SRF 
(Pellegrini et al., 1995; Mo et al., 2001). SRF binds to a consensus motif named CArG 
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box: CC[A/T]6GG. Degenerate CArG box motifs are widespread in the genome. 
Computational analyses predict more than 3 million such CArG box motifs in human 
genome (Sun et al., 2006). SRF ChIP-seq, however, revealed only thousands of peaks 
in each cell type (Kim et al., 2010; Sullivan et al., 2011; Esnault et al., 2014). This 
suggests the functional binding of SRF may be regulated by other mechanisms such as 
chromatin regulation. SRF can be regulated by transcriptional induction, post-
translational modification, and cofactor interaction. SRF is constitutively expressed, and 
it can activate its targets without new protein synthesis. But its transcription can also be 
further induced by Rho-actin pathway activators (Esnault et al., 2014; Misra et al., 
1991). SRF has two phosphorylation sites: Thr-159 and Thr-162. Phosphorylation of 
Thr-159 in the MADS domain is required for transcriptional activation of the α-actin gene 
(Iyer et al., 2003). Phosphorylation of Thr-162 prevents SRF binding at the actin 
promoter, but it does not prevent SRF binding at the promoter of c-fos (Iyer et al., 2006). 
This is probably because SRF activity requires different cofactors at these two genes. 
And different phosphorylation can affect the choice of cofactor to selectively activate 
SRF targets.  
 
SRF activity is mainly regulated through cofactor interaction (Figure 1-3). SRF can 
interact with two cofactors: ternary complex factor (TCF) and myocardin-related 
transcription factor (MRTF) transcription factors. TCF transcription factors consist of 
three members: SAP-1, Elk1, and Net. TCF belongs to the ETS family transcription 
factors. In the presence of nearby SRF sites, TCF can bind cooperatively with SRF and 
form a ternary complex on DNA in the absence of stimulation (Posern and Treisman, 
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2006; Herrera et al., 1989). Because TCF contacts SRF through a flexible domain, they 
can form a complex with variable spacing between the two binding sites (Treisman et 
al., 1992). The MAPK pathway can activate TCF in the ternary complex through 
phosphorylation. Active TCF can further recruit CBP/p300, histone modifiers, and 
transcription initiation machinery for transcriptional activation (Ramirez et al., 1997; 
Esnault et al., 2017). The MAPK-TCF pathway can be activated by a broad range of 
stimuli including mitogens, cytokines, UV irradiation, and TLR agonists (Chai and 
Tarnawski, 2002). SRF and TCF control the expression of many primary response 
genes that regulate cell proliferation and differentiation, such as c-fos, Egr1, and Nr4a1.  
 
Myocardin-related transcription factors (MRTFs) belong to another family of SRF 
cofactors. This family consists of myocardin, MRTFA, and MRTFB. Myocardin is 
selectively expressed in muscle cells. Myocardin is constitutively active and controls the 
expression of many muscle-specific genes (Wang et al., 2003). MRTFA and MRTFB are 
expressed ubiquitously in many cell types. MRTF is sequestered by monomeric actin in 
the resting state. Activation of the Rho-actin pathway induces actin polymerization, 
which dissociates actin from MRTF. MRTF then translocates to the nucleus and 
complexes with SRF (Miralles et al., 2003; Olson and Nordheim, 2010). Although MRTF 
also makes DNA contact in the SRF-MRTF complex, it does not bind to DNA in a 
sequence-specific manner; it is recruited to the SRF motif by SRF (Zaromytidou et al., 
2006). The MRTF-SRF complex regulates genes involved in actin cytoskeleton function, 
cell migration, and muscle function (Olson and Nordheim, 2010; Medjkane et al., 2009). 
Because MRTF and TCF bind to a common interface on SRF, they can compete for 
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SRF interaction, resulting in either the activation or repression of transcription 
(Zaromytidou et al., 2006; Murai and Treisman, 2002; Wang et al., 2004). The 
competition of different cofactors enables SRF to integrate multiple signals and 
selectively activate transcription.  
 
In conclusion, a proper immune response requires a fine balance between host defense 
and homeostasis. Clarifying the mechanisms underlying the immune activation will 
improve our understanding of the immune system and will shed light on treating 
immune-related diseases. Because innate immunity orchestrates a chain of innate and 
adaptive immune responses during inflammation, we began our studies on the innate 
immune response. Innate immune cells can sense pathogen components through 
pattern recognition receptors, which reside in different cellular compartments and trigger 
potent transcriptional induction integrating discrete signaling pathways, chromatin 
regulators, and transcription factors. The highly coordinated events regulating the 
transcriptional cascades require both common and gene-specific strategies that allow 
innate immune cells to respond in cell-specific and stimulus-specific manners. Although 
many studies have investigated the transcriptional mechanisms of different pattern 
recognition receptors, they relied on statistics and conventional systems approaches 
that focus on common regulatory mechanisms. Their approaches assume that one 
transcription factor or pathway can regulate many genes, and combinatorial regulation 
leads to gene-specific regulation. However, their statistic methods require large sample 
sizes, and therefore, they often suffer from the loss of selective mechanisms that only 
regulate a small number of genes. In chapter 2, I describe a stringent system approach 
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to classify primary and secondary response genes. This approach demonstrates that 
key inflammatory genes are regulated by highly selective mechanisms involving 
chromatin regulation and combinatorial regulation. In chapter 3, I examine a 
combinatorial regulation model of SRF and TCF transcription factors and identify the 
strict motif requirements for cooperative binding and transcriptional induction. Taken 
together, our stringent systems approach can complement the conventional systems 
approach by uncovering selective mechanisms and by elucidating deeper mechanistic 
details in complicated contexts.  
 
 
 
Figure Legends 
 
Figure 1-1: TLR4 Signaling Pathways 
LPS-activated TLR4 signaling is mediated through two adaptors: TIRAP/MyD88 and 
TRIF. Dimerization of TLR4 recruits TIRAP/MyD88, which in turn recruits IRAKs, 
TRAF6, TAB1/2/3, TAK1, IKKα, IKKβ, and the regulatory subunit IKKγ. Active IKKs can 
phosphorylate IκBs and activate the NFκB pathway. Active TAK1 in the cytoplasm can 
activate the MAPK pathway. Through CD14-mediated activation of ITAM, Syk and 
PLCγ, TLR4 can internalize and transport to endosome. In endosome, TLR4 interacts 
with the adaptor TRAM/TRIF, which in turn recruits RIPK1, TRADD, caspase-8, FADD, 
IKKα, IKKβ, and IKKγ. Active IKKs can induce the NFκB pathway. TRAM/TRIF can also 
recruit TRAF3, which can interact with TANK, IKKγ, IKKε, and TBK1. TBK1 can activate 
IRF3, a key transcription factor responsible for type I IFN production.  
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Figure 1-2: Cell-Specific and Stimulus-Specific Regulation of Gene Transcription  
A model explains the cell-specific and stimulus-specific regulation of transcription. 
During cell development, micro-environmental cues induce the expression of pioneer 
transcription factors and polarizing transcription factors. They can promote cell-specific 
gene expression program and drive lineage commitment and cell differentiation. In the 
peripheral tissue, terminally differentiated cells can respond to extracellular and 
intracellular stimuli by inducing different effector transcription factors. These stimulus-
specific transcription factors can induce gene expression programs resulting in 
reversible functional states.  
 
Figure 1-3: SRF Regulated by Rho-MRTF and MAPK-TCF Pathways 
SRF can partner with two cofactors: MRTF (MAL) activated by the Rho-actin pathway, 
and TCF activated by the MAPK pathway. Monomeric actin can bind to MRTF (MAL) 
and sequester MRTF (MAL) in the cytoplasm. Activation of the Rho family GTPases 
(RhoA, Rac, and Cdc42) induces actin polymerization and dissociates monomeric actin 
from MRTF (MAL). MRTF can translocate into the nucleus and complex with SRF to 
activate transcription. The MAPK pathway can phosphorylate and activate TCF. TCF 
binds to the Ets site near SRF site. TCF can bind cooperatively with SRF and form a 
ternary complex to activate transcription.   
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Figure 1-1: TLR4 Signaling Pathways 
(Brubaker et al., 2015; License#: 4082740867171) 
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Figure 1-2: Cell-Specific and Stimulus-Specific Regulation of Gene Transcription 
 (Ostuni and Natoli, 2013; License#: 4082741209330) 
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Figure 1-3: SRF Regulated by Rho-MRTF and MAPK-TCF Pathways 
(Posern and Treisman, 2006; License#: 4082741323052) 
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Abstract 
Although ChIP-seq data reveal that a transcription factor can bind to thousands of 
genomic sites, expression data suggest that only a subset of these sites contribute to 
transcription. This discrepancy indicates that transcription factor binding is often 
insufficient for transcriptional activation and the functional sites require selective 
regulation. In this study, we described a gene-centric, stringent system approach to 
investigate the selective mechanisms regulating serum response factor (SRF) in a lipid 
A response. SRF can activate transcription through the combinatorial interaction with 
cofactors such as ternary complex factor (TCF). By combining well-defined gene 
clusters, motif data, and ChIP-seq data, we found that the Toll-like receptor 4 (TLR4) 
agonist lipid A selectively and strongly activated a small number of SRF targets. All 
promoter-activated SRF targets share a unique, strict, and conserved SRF-TCF 
cassette. This SRF-TCF cassette is essential for the strong promoter SRF binding and 
the cooperative binding of TCF. Furthermore, formation of ternary complex at the SRF-
TCF cassette also requires an open chromatin at the promoter. Enhancer-activated 
SRF targets possess SRF and TCF motifs similar to promoter SRF-TCF cassettes. The 
function of SRF-TCF cassettes is further confirmed in different cell types and by 
different stimuli. These findings demonstrate that the selective and combinatorial 
regulation of SRF targets require strict motif rules. They also exemplify a gene-centric, 
stringent system approach to identify functional binding events that directly contribute to 
transcriptional induction. 
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Introduction 
Discovered thirty years ago, serum response factor (SRF) is a well-studied transcription 
factor that led to many important discoveries in gene regulation. SRF was originally 
discovered as a factor that can rapidly activate c-fos gene within 15 minutes of serum or 
growth factor stimulation (Greenberg and Ziff, 1984; Treisman, 1986; Norman et al., 
1988). SRF binds to a consensus sequence CC(A/T)6GG, named the CArG box. This 
CArG box exists at the promoters of many SRF targets. SRF targets often respond 
rapidly to environmental stimuli through existing signaling molecules. Thus, they are 
called immediate early genes, or primary response genes. Conversely, genes that 
exhibit late kinetics and require new protein synthesis are called secondary response 
genes (K R Yamamoto et al., 1976; Herschman, 1991). The separation of primary and 
secondary response genes is often the first step to dissect stimulus-induced 
transcriptional cascades (Ramirez-Carrozzi et al., 2009; Tong et al., 2016).  
 
Serum response factor (SRF) is an MADS (MCM1, Agamous, Deficiens, and SRF) box 
family transcription factor, which contains a conserved MADS box domain for DNA-
binding. Mammalian SRF is ubiquitously expressed in many cell types and is critical for 
cell survival and cellular responses to many environmental stimuli. SRF can react to 
mitogens including serum, growth factors, cytokines, lipopolysaccharide, and 
tetradecanoylphorbol-13-acetate. Mitogens can activate SRF targets regulating cell 
cycle, cell proliferation, apoptosis, cell differentiation, circadian rhythm, and cytoskeleton 
functions (Posern and Treisman, 2006; Medjkane et al., 2009; Gerber et al., 2013). Cell-
specific activation of SRF targets is often involved in maintaining cell identity and 
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regulating cell-specific functions (Miano, 2010). For example, SRF can collaborate with 
muscle-specific factors to regulate the expression of many muscle-specific genes 
regulating the development of cardiac muscle cells, smooth muscle cells, and skeletal 
muscle cells. Heart-specific mutation of SRF impairs cardiac development and is 
embryonic lethal (Parlakian et al., 2004). In hematopoietic stem cell progenitors, SRF is 
responsible for cell migration and cell seeding in response to chemokine signaling 
(Costello et al., 2015). In macrophages, SRF is essential for phagocytosis by regulating 
cytoskeletal functions (Sullivan et al., 2011).   
 
Although SRF can undergo several post-translational modifications, active SRF is 
insufficient for gene activation. SRF activity also depends on the combinatorial 
interaction with co-factors. SRF binds to DNA constitutively and interacts with at least 
two competing co-factors: ternary complex factor (TCF) transcription factors (Elk-1, 
SAP1, and Net), and myocardin-related transcription factors (MRTF) (myocardin, 
MRTF-A, MRTF-B). Stimulus-induced MAPK pathway can phosphorylate and activate 
TCF (Dalton and Treisman, 1992; Posern and Treisman, 2006). TCF binds to an Ets 
site and interacts with SRF through a flexible domain, which allows for stable ternary 
complex formation with variable spacing between the Ets site and the CArG box 
(Treisman et al., 1992). Because the formation of ternary complex stabilizes TCF 
binding on DNA, TCF can tolerate a suboptimal Ets site. Among MRTF transcription 
factors, myocardin is selectively expressed and constitutively active in smooth muscle 
and cardiac cells (Pipes et al., 2006; Posern and Treisman, 2006). The other two MRTF 
members, MRTF-A and MRTF-B, are widely expressed in many cell types and are 
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induced by Rho-actin pathway. In resting cells, actin monomer binds to MRTF and 
inhibit MRTF nuclear translocation. Activated Rho pathway induces actin polymerization 
and releases actin from MRTF, resulting in MRTF activation and nuclear translocation 
(Vartiainen et al., 2007; Pawłowski et al., 2010). MRTF does not bind directly to DNA in 
a sequence-specific manner; it is recruited to the SRF motif by SRF to activate 
transcription. Because MRTFs and TCFs bind to the same interface on SRF, they can 
compete for SRF binding, resulting in either gene activation or repression (Murai and 
Treisman, 2002; Zaromytidou et al., 2006; Wang et al., 2004; Gualdrini et al., 2016). 
Therefore, by using different co-factors, SRF targets can integrate different extracellular 
signals into transcriptional outcomes and balance different cellular responses.  
 
Previous biochemical and computational studies have given us many insights on the 
mechanisms regulating SRF targets. Site selection experiments discovered that the 
consensus motif of SRF, the CArG box, is a degenerate sequence (Pollock and 
Treisman, 1990). Computational analyses have identified hundreds of potential 
promoter CArG boxes in human and mouse genomes (Sun et al., 2006). The emerging 
next-generation sequencing technologies, including chromatin-immunoprecipitation 
sequencing (ChIP-seq) and Hi-C, uncovered thousands of in vivo SRF binding sites in 
different cell types. SRF ChIP-seq data suggest that SRF can bind to canonical CArG 
boxes as well as non-canonical CArG boxes with mismatches (Esnault et al., 2014; He 
et al., 2011; Sullivan et al., 2011). SRF binding at different genomic locations contribute 
to the differential gene expression patterns. For example, SRF binds to promoters to 
regulate ubiquitously expressed genes; SRF binds to enhancers established by pioneer 
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factors to activate cell-specific genes (Sullivan et al., 2011; Kim et al., 2010; He et al., 
2011). Because SRF activity is the dependent on co-factor interaction, most SRF peaks 
are constitutive and coincide with either MRTF or TCF binding (Gualdrini et al., 2016; 
Esnault et al., 2014). SRF ChIP-seq data also suggest that SRF binding is insufficient 
for gene activation. Selective recruitment of MRTF or TCF factors is critical for 
transcriptional activation (Vasudevan and Soriano, 2014).  Although previous SRF 
ChIP-seq analyses have revealed many characteristics of SRF, their peak-centric 
statistical approaches are restricted by large sample sizes and are therefore biased 
towards co-regulatory mechanisms. To unveil the selective mechanisms regulating SRF 
function, we need to use a different strategy.  
 
In this study, we describe a gene-centric approach to identify the motif rules that 
selectively activate SRF targets in the innate immune response. By identifying SRF 
targets and studying the motif characteristics, binding strength, and DNA context, we 
prevented the interference of non-functional sites and focused on the mechanisms 
controlling functional SRF sites. This enabled us to characterize a small subset of SRF 
targets sharing a unique promoter SRF-TCF cassette responsible for SRF activity. 
Owing to the relative few ChIP-seq peaks and abundant evidence from previous 
studies, SRF serves as a good example to optimize the strategies to interrogate the 
selective mechanisms regulating transcription.  
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Results 
General Features of SRF ChIP-Seq in Macrophages 
To understand the mechanisms regulating SRF activity in the lipid A response, we 
performed ChIP-seq experiments in bone marrow-derived macrophages (BMDMs) 
stimulated with lipid A for 0, 15, 30, 60, and 120 minutes. We eliminated the non-
specific peaks that also showed up in SRF knockout samples (Sullivan et al., 2011). 
Consistent with the previous studies, SRF binds to DNA before stimulation (Li et al., 
2003; Nissen et al., 2001). Most peaks bind constitutively and remain unchanged within 
two hours of lipid A stimulation (Figure 3-1A). Because weaker peaks are less 
reproducible and are more likely to represent technical artifacts, we treated samples of 
five time points as replicates and uncovered 718 reproducible peaks reaching a peak 
score threshold of 10. Strikingly, these SRF peaks are highly enriched in the promoter 
region (Figure 3-1B and C). Almost one fifth of the SRF peaks fall into the promoter 
region (-500 to +150 relative to TSS).  
  
Although more than half of the promoters contain CpG islands, 91.6% of the SRF 
promoter peaks contain CpG islands with an obs/expt CpG ratio greater than 0.6 
(Figure 3-1D). Because CpG-island promoters are too rigid to form stable nucleosomes, 
they are generally constitutively accessible to transcription factors without the need of 
chromatin remodeling (Ramirez-Carrozzi et al., 2009). Thus, they are often associated 
with housekeeping genes and other ubiquitously expressed genes. The prevalence of 
CpG-island promoters might suggest that SRF binding at promoters tend to regulate 
ubiquitously expressed genes. In contrast to promoters, fewer than 15% of the SRF 
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enhancer peaks have CpG islands (Figure 3-1E), and their CpG content is similar to 
active enhancer peaks identified by H3K27ac ChIP-seq peaks. The differential CpG 
content in SRF promoter and enhancer peaks might simply reflect the depletion of CpG 
in non-promoter regions of mammalian genomes. It might also reflect the different 
strategies that SRF deploys to regulate genes involved in different biological functions. 
One study found that SRF regulates ubiquitously expressed genes by promoter binding 
and regulates cell-specific genes by binding to enhancers established by pioneer factors 
(Sullivan et al., 2011; Heinz et al., 2010). Because promoters are better characterized 
than enhancers, we decide to start our analysis from SRF promoter peaks.   
 
Identify SRF Targets Induced by Lipid A  
In macrophages, lipid A-induced TLR4 signaling can trigger the MAPK pathway, which 
in turn phosphorylates TCF and induces transcriptional activation of SRF targets. 
Previously, we stimulated bone marrow-derived macrophages (BMDMs) with lipid A and 
monitored nascent transcript expression by collecting samples every five minutes during 
the first hour of stimulation (Tong et al., 2016). To prevent the interference of mRNA 
stability, we isolated nascent transcripts associated with chromatin and measured 
transcript levels by RNA-sequencing. Because SRF targets are often transiently 
induced between 10 to 30 min, a large number of time points can capture the peak 
transcription of SRF targets. Using stringent criteria that include a fold change threshold 
of 10 and a maximal expression threshold of 3 RPKM, we identified 226 lipid A-induced 
genes.  
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To uncover the common features and potential rules for SRF to activate transcription, 
we focused on the well-defined SRF targets. We found that lipid A activated only eight 
SRF targets (Figure 3-2A). These eight SRF targets are distinct from other lipid A-
induced genes by their early transient transcriptional kinetics. They are activated by 5 
min and peaked by 20 min. They are transiently induced because the upstream of SRF-
TCF, MAPK, is transiently activated during the lipid A response. Consistently, all SRF 
targets are strongly repressed by a cocktail of MAPK inhibitors (ERK inhibitor, 
PD0325901; p38 inhibitor, BIRB796). All eight SRF targets are categorized as primary 
response genes, which depend on existing signaling molecules and are insensitive to 
the inhibitor of translation, cycloheximide. Six of the SRF targets (Egr1, Egr2, Dusp5, 
Fos, Zfp36, Nr4a1) have SRF binding and CpG islands at their promoters (Figure 3-2B). 
Another two SRF targets (Ier2, Btg2) have SRF binding at enhancer regions within 10kb 
upstream of their transcription start sites (TSSs), which coincide with the active 
enhancer mark H3K27ac (Figure 3-2B). 
 
Interrogate Functional SRF Peaks Combining Motif Data and ChIP-seq Data. 
To understand the requirements for functional SRF binding that lead to gene activation, 
we evaluated the correlation of promoter motif strength and peak strength of different 
gene classes. By their activation mechanisms and transcriptional kinetics, we separated 
the mouse genome into five categories: primary response genes, secondary response 
genes, 2- to 10-fold induced genes, not induced genes, and low expression genes. We 
compared the promoter SRF ChIP-seq peak score and the motif score using the 
Transfac database (Wingender et al., 1996; Kaplun et al., 2016). Only primary response 
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genes exhibit a clear correlation between promoter motif strength and peak strength. 
While no weak promoter SRF motif has binding, seven of nine primary response genes 
with strong promoter motifs have SRF binding (Figure 3-3A). Notably, six of these seven 
strong promoter motifs belong to previously defined SRF targets by RNA-seq. Although 
another two primary response genes possess strong promoter SRF motifs, their SRF 
sites reside farther (-306 and -331) upstream of transcription start sites than SRF 
targets, and therefore they may be occupied by nucleosomes and are inaccessible to 
SRF binding. Consistently, theses two SRF sites are not conserved in mammalian 
species. In contrast to primary response genes, none of the other gene classes show 
such strong correlation between strong motif and strong binding. While 5.3% of the 
primary response genes contain strong promoter SRF motif with strong binding, only 
less than 0.7% of genes in the other classes show similar strong binding and strong 
motif (Figure 3-3A and B). Many classes have promoter SRF binding without strong 
SRF motifs, which might represent indirect or non-functional binding. The enrichment of 
strong motifs and strong binding at primary response genes suggests that strong motifs 
combining strong binding is necessary for SRF transcriptional activity in a lipid A 
response.  
 
Because functionally important cis-regulatory elements are often conserved, we 
quantified the conservation score of the SRF motifs by PhastCons (Siepel et al., 2005). 
In primary response genes, six of the seven strong promoter motifs with strong binding 
are highly conserved with a score greater than 0.997 (Figure 3-3C, in black). In contrast, 
only 6 of 123 weak promoter SRF motifs of primary response genes reach such high 
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conservation score. Interestingly, none of the other two strong SRF motifs without 
binding is conserved, suggesting they might not contribute to transcription in the lipid A 
response. Promoters with strong SRF motifs and strong binding are more conserved 
regardless of their gene classes. This indicates that strong motifs with strong binding 
might be functionally important in different contexts. Although many promoters do not 
respond to lipid A stimulation, they might react to other stimuli through different 
mechanisms. The enhancer sites, however, show a different trend. Although they are 
more conserved than the predicted strong enhancer SRF motifs without binding, 
enhancer peaks with strong motifs are less conserved than promoter peaks with strong 
motifs. It is possible that many enhancer SRF peaks react to cell-specific and stimulus-
specific signals, and therefore they are less conserved than the promoter sites 
regulating ubiquitously expressed genes, which are essential for developmental and 
cellular functions. Unlike promoter peaks, strong enhancer SRF motifs do not exhibit 
stronger conservation than weak enhancer SRF motifs. This indicates that the 
regulation of SRF at promoter and enhancer sites require different mechanisms.   
 
Identify a Promoter SRF-TCF Cassette Required for Gene Induction  
Although strong SRF motifs with strong binding are highly correlated with transcriptional 
activation by lipid A, another 39 promoters with strong SRF motifs and strong binding 
failed to strongly induce transcription. This implies that either SRF activity depends on 
other factors such as TCF, or there are subtle differences in SRF motifs that motif score 
cannot reveal. To address these possibilities, we compared the promoter SRF motifs in 
different gene classes. Because ETS family transcription factor TCF can bind to SRF 
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and form a ternary complex, which can stabilize TCF binding and tolerate a suboptimal 
Ets site near SRF site, we also scanned for the nearest Ets site using the motif-
searching tool Pscan (Zambelli et al., 2009).  
 
Intriguingly, all six SRF targets with promoter SRF binding share a strict SRF-TCF 
cassette (Figure 3-4A). Although the reported SRF consensus sequence can tolerate 
either A or T in the center six base pairs, we found all six SRF targets shared a more 
stringent SRF motif, which includes an ATA sequence on one side of the motif. These 
sites also contain a consensus Ets motif that is within 19bp of SRF motif. This is 
consistent with the previous discovery that TCF can physically interact with SRF 
through a flexible domain and tolerate short and variable spacing between the two 
motifs (Treisman et al., 1992). Thus, we have defined a unique SRF-TCF cassette 
shared by all six SRF targets: an SRF motif CCATA(A/T/C)(A/T)(A/T)GG, a TCF motif 
(CC/CA/GA)GGA, with 3 to 19-bp motif spacing. We also noticed that an additional 
primary response gene, Rnd3, also contains an SRF motif and an Ets motif, but the 
motif spacing between the two sites is only 1bp. Rnd3 is not activated by SRF in the 
lipid A response, probably because the motif distance is too small for ternary complex 
formation. Structural evidence also suggests that ternary complex formation requires 
more than 1-bp spacing (Hassler, 2001). Furthermore, EMSA experiments have shown 
that SRF and TCF failed to form a ternary complex on a DNA probe with only 1-bp 
spacing between the SRF and TCF motifs (Treisman et al., 1992). 
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When we used the above definition of the SRF-TCF cassette to examine the other 39 
promoters combining strong SRF binding with strong motifs, we found only 2 of the 39 
promoters contain similar SRF-TCF cassettes: Fosb and Glipr1. Interestingly, both 
genes showed rapid transcriptional kinetics like SRF targets. Both genes peaked by 20 
min of lipid A stimulation and were repressed by MAPK inhibitors (Figure 3-4B and C). 
Although Fosb is induced more than ten fold, its maximal RPKM is below our threshold 
of 3. Although Glipr1 exceeds our maximal RPKM threshold, its fold change is 5.9, 
which is lower than our fold change threshold of 10. Because Fosb is a close related 
family member of another SRF target, Fos, it is likely that these two genes are regulated 
by similar mechanisms. Although Fosb and Glipr1 missed our stringent criteria for 
strongly induced genes, they have substantial transcriptional induction and expression 
levels, so they appear to be functional SRF targets that were mis-categorized in our 
previous analysis. Thus, using this defined SRF-TCF cassette, we accidentally found 
another two SRF targets induced by lipid A. This further indicates that the SRF-TCF 
cassette may be sufficient to identify SRF targets regulated by promoter binding.  
 
Only Nine Additional Promoters Contain SRF-TCF Cassettes  
Because we defined the promoter SRF-TCF cassette solely from six SRF targets, it is 
possible that we might experience a survivor bias; SRF-TCF cassettes might also exist 
in other promoters but is unnecessary or insufficient for gene induction. To address this 
problem, we scanned 21013 promoters in the mouse genome for additional SRF-TCF 
cassettes. In addition to the above eight SRF targets, the defined SRF-TCF cassette 
only exists in another nine promoters. All of these nine promoters lack SRF binding and 
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were not activated by lipid A (Figure 3-5A). It is likely that their SRF-TCF cassettes lack 
transcription factor binding because of nucleosome occupation.  
 
Because promoter CpG content often dictates nucleosome stability, we first assessed 
their chromatin states by comparing the promoter CpG content between SRF targets 
and these nine promoters lacking SRF binding. While seven of eight SRF targets have 
CpG ratio greater than 0.9, none of the nine promoters without SRF binding reach such 
high CpG ratio (Figure 3-5B). The lower CpG content at the nine promoters lacking SRF 
binding supports that their promoters tend to possess well-positioned nucleosomes and 
are inaccessible for SRF binding.  
 
Consistent with the above CpG content data, ATAC-seq data also showed that all SRF 
targets have accessible promoters. In contrast, only three of the nine promoters without 
SRF binding are accessible with strong ATAC-seq signals (Figure 3-5C). H3K4me3 
mark for active promoters also aligned with the CpG content and ATAC-seq data. While 
all SRF targets have strong H3K4me3 signal, only three of the nine promoters lacking 
SRF binding (Rhoj, Tnfsf14, and Gpr183) are active promoters with strong H3K4me3 
signals. However, SRF motifs of these three promoters are located beyond the 
functional range of SRF motifs in SRF targets (Figure 3-5D). While promoter SRF motifs 
of SRF targets are between 42bp to 410bp upstream of the TSS, one promoter SRF 
motif without SRF binding (Tnfsf14) is located farther upstream of the TSS, which is far 
from the accessible promoter region. Another two promoter SRF sites without SRF 
binding (Rhoj and Gpr183) are at the proximal downstream of the TSS. These two SRF 
  87 
sites may be occupied by the +1 nucleosome, a well-positioned nucleosome 
downstream of the TSS (Jiang and Pugh, 2009; Bai and Morozov, 2010). Therefore, the 
additional nine SRF-TCF cassettes probably lack SRF binding because they are located 
within inaccessible promoter regions.  
 
Because eight of the nine genes with promoter SRF-TCF cassettes lacking SRF binding 
have undetectable expression in resting macrophages (data not shown) and appear to 
require chromatin regulation, their transcriptional activation may require other stimulus-
specific or cell-specific transcription factors that can trigger chromatin remodeling. One 
of these nine genes, Vil1, is such an example. Vil1 is selectively expressed in epithelial 
cells. Bacterial infection can activate Vil1 by inducing SRF-TCF pathway in epithelial 
cells (Rieder et al., 2005).  
 
Therefore, by evaluating the prevalence of the defined SRF-TCF cassette at all 
promoters, we confirmed that the defined SRF-TCF cassette is a unique feature of SRF 
targets. The defined SRF-TCF cassette is probably necessary for inducing SRF targets 
through the MAPK pathway. It also suggests that an accessible chromatin context is 
essential for ternary complex formation and function at the defined SRF-TCF cassette. 
 
SRF Targets Possess the Strongest SRF Promoter Peaks 
Further examination of SRF targets revealed that their promoter SRF-TCF cassettes 
also coincide with exceptionally strong SRF peaks. Among the strongest fifteen 
promoter peaks, eight of them contain strong SRF motifs. And six of these eight SRF 
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peaks with strong SRF motifs belong to SRF targets, often dwarfing most of the peaks 
on the same chromosome (Figure 3-6A and B). For example, the Egr1 promoter peak is 
the strongest peak on chromosome 18 (Figure 3-6B). One likely explanation for this 
observation is the cooperative binding of TCF, which can stabilize SRF binding to DNA 
by forming a ternary complex (Shore and Sharrocks, 1994; Shore et al., 1996). In 
mouse embryonic fibroblasts, mutating TCF transcription factors strongly impaired SRF 
binding (Gualdrini et al., 2016).  
 
However, another two SRF targets (Zfp36 and Fos) containing promoter SRF-TCF 
cassettes do not exhibit exceptionally strong SRF binding. This suggests that the 
exceptionally strong binding at six SRF targets might be supported by other 
mechanisms as well. One likely mechanism is the collaboration of SRF with other 
transcription factors. To uncover potential collaborating transcription factors, we 
compared motif enrichment of promoters with stronger (peak score>30) and weaker 
(peak score<30) SRF binding. While all promoter peaks are highly enriched with the 
SRF motif, the stronger SRF peaks are also enriched with motifs of CREB/ATF family 
transcription factors (Figure 3-6C). To determine whether CREB can promote SRF 
binding, we evaluated the CREB motif strength and CREB-SRF motif spacing in all 
promoters with strong SRF binding and strong SRF motifs (Figure 3-6D and E). 
Interestingly, all six SRF targets with exceptionally strong binding contain TCF motifs 
and strong CREB motifs (motif score >0.87) within 70bp of SRF motifs. Moreover, all 
these six SRF target promoters have strong CREB ChIP-seq peaks (Figure 3-6E and 
F). Another two promoters (Egr4 and Filip1l) also have strong CREB motifs near SRF 
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motifs. However, both promoters lack strong CREB binding. This is probably because 
their CREB sites are inaccessible by nucleosome occlusion. Although we cannot 
exclude the possibility that CREB binding at these six targets may be a coincidence, it is 
very likely that the proximal CREB binding may enhance SRF binding to six SRF targets 
through direct or indirect mechanisms. For example, CREB might physically interact and 
stabilize the SRF-TCF complex. Or it might facilitate SRF binding by bending DNA or 
excluding nucleosomes to increase chromatin accessibility.   
 
Besides CREB, there may be other explanations for the exceptionally strong SRF 
binding at six SRF targets. Another two genes, Srf and Bcl2l11, also have exceptionally 
strong SRF binding and strong SRF motifs, but lack strong CREB motifs near SRF 
motifs (Figure 3-7A). However, both of their promoters contain more than one SRF site, 
which can potentially enhance the binding affinity of SRF (Figure 3-7A). To evaluate the 
importance of motif copy number, we scanned for additional SRF motifs at the 
promoters of SRF targets. Four of the SRF targets with the strongest peaks (Egr1, Egr2, 
Dusp5, and Glipr1) have more than one SRF site at their promoters. In Egr1 promoter, 
there are six SRF sites and multiple Ets sites spanning two SRF peaks (Figure 3-2B, 
Figure 3-7A and B). Interestingly, Egr2 shares a similar pattern with Egr1. Egr2 also has 
two promoter peaks covering multiple SRF and Ets sites. It is very likely that Egr1 and 
Egr2 use similar mechanisms to regulate transcription by SRF and TCF. And it is also 
interesting to understand whether the two adjacent promoter peaks function 
cooperatively or redundantly. Taken together, these findings suggest that the 
exceptionally strong binding of SRF at SRF targets might depend on more than one 
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mechanism. Besides the role of TCF in stabilizing SRF binding, the binding of CREB 
near SRF and multiple copies of SRF motifs might also contribute to the exceptionally 
strong binding of SRF.   
 
To determine whether the above mechanisms for promoter peaks also apply for 
enhancer peaks, we examined the SRF motif strength and peak strength of the 552 
SRF enhancer peaks (Figure 3-8A). Because it is difficult to correlate enhancer peaks 
with their targets, and it is hard to separate functional enhancers by gene transcription, 
we did not observe any clear correlation between the motif strength and peak strength. 
To assess whether the strong SRF enhancer peaks correlates with Ets motifs or CREB 
motifs, we searched for the nearest Ets motifs and the best CREB motifs near SRF 
motifs. Because the motif requirements for functional binding at enhancers may differ 
from those at promoters, we used less stringent criteria for enhancer SRF-TCF motifs 
than the defined promoter SRF-TCF cassette. We first found the best SRF motif; then 
we searched for the nearest Ets motif and the best CREB motif near an SRF motif.  
 
The strongest enhancer peaks exhibit a different motif pattern from the strongest 
promoter peaks. While six of eight strongest promoter peaks contain strong SRF, Ets, 
and CREB motifs, only two of sixteen strongest enhancer peaks contain all three motifs. 
Notably, these two enhancer peaks are near Btg2 and Ier2—two SRF targets identified 
by expression data (Figure 3-2A and Figure 3-8B). Another potent enhancer peak, 
containing only SRF and Ets motifs, is around 3kb upstream of Egr3, a gene that is 
closely related to another two SRF targets, Egr1 and Egr2. Although Egr3 has relatively 
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low expression level (RPKM<1), which is below our threshold for expressed genes 
(RPKM>3), it is rapidly and transiently induced like other SRF targets (Figure 3-8C). 
And its induction was sensitive to MAPK inhibitors. Another two enhancer peaks contain 
both SRF motifs and CREB motifs but lack Ets motifs near SRF motifs. Consequently, 
their closest genes, Junb and Ubald1, are not strongly induced by lipid A. Although the 
motif sequences at enhancer peaks are slightly different from the defined promoter 
SRF-TCF cassettes of SRF targets, we found that SRF-TCF motifs combining strong 
SRF binding are sufficient to identify functional enhancer peaks. Thus, by studying the 
mechanisms of SRF regulation at promoters, we were able to extend similar analyses to 
enhancers and found that ternary complex formation can regulate transcription at both 
promoters and enhancers. 
 
MRTF May Regulate Other Promoter SRF Peaks with Strong Motifs  
Besides the six SRF targets, another two genes also contain exceptionally strong 
promoter SRF peaks and strong SRF motifs: Srf and Bcl2l12 (Figure 3-6A). Because 
these two genes lack the defined promoter SRF-TCF cassette and are not activated by 
the MAPK pathway, they might be regulated by another SRF cofactor, MRTF. Upon 
activation of Rho-actin pathway, MRTF can translocate into nucleus and bind to SRF to 
activate SRF targets. Published data in fibroblasts showed that Cytochalasin D (CytoD), 
a strong activator of Rho-actin pathway, induced Srf and Bcl2l12 by more than five fold 
(He et al., 2011, Figure 3-9A and B). Moreover, serum stimulation, a mild activator of 
MRTF, led to MRTF binding at the promoter of Srf, coinciding with SRF binding (Figure 
3-9C). These findings suggest that MRTF might regulate other promoter SRF peaks that 
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lack the defined SRF-TCF cassettes.  
 
To evaluate whether the other 37 promoters combining strong SRF peaks and strong 
SRF motifs are regulated by the SRF-MRTF pathway, we compared gene induction by 
CytoD in fibroblasts and by lipid A in macrophages (Figure 3-9D and E). While most 
SRF targets were preferentially induced by lipid A, 12 of 37 genes with strong SRF motif 
and binding were preferentially induced by CytoD (fold change>5, max RPKM>3). 
Moreover, seven of these CytoD-inducible genes also have MRTF peaks at their 
promoters following serum stimulation (Figure 3-9D). The other five genes lack MRTF 
binding, probably because serum stimulation is a weaker activator of MRTF than CytoD. 
Another 25 genes were not strongly induced by CytoD. Their activation might require 
stronger stimulation or other factors. Taken together, these data support that MRTF 
might regulate a subset of promoter SRF peaks with strong motifs that lack SRF-TCF 
cassettes. Because MRTF binds to SRF only after stimulation and it might not stabilize 
SRF binding like TCF, the SRF peaks regulated by MRTF are weaker than those with 
SRF-TCF cassettes.  
 
Ternary Complex Formation Can Enhance SRF Binding and H3K4me3 Mark  
Because TCF binding coincides with the strongest SRF peaks at promoters and 
enhancers, we first evaluated its contribution to SRF binding and transcription by 
mutating Ets sites in immortalized macrophages using CRISPR. To avoid the effects of 
redundant sites, we mutated the SRF or Ets site at the Nr4a1 promoter, which has only 
one SRF site and one Ets site. To get maximal gene induction, we stimulated the 
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immortalized macrophages with lipid A and serum simultaneously. For each CRISPR 
mutation, we selected two mutant clones as biological replicates. Mutating the Ets site 
strongly diminished SRF binding at the Nr4a1 promoter (Figure 3-10A). This supports 
the hypothesis that TCF binds cooperatively with SRF and enhances SRF binding to 
DNA. However, while mutating the SRF site decreased SRF binding to less than 5% of 
maximal SRF binding, mutating the TCF site still retained about 25% of SRF binding. 
The residual SRF binding in the absence of TCF indicates that SRF can bind 
autonomously. In contrast, TCF binding at the Nr4a1 promoter seems to be completely 
dependent on SRF. The binding of a TCF family member SAP1 is decreased to similar 
level by mutating either the SRF or Ets site (Figure 3-10B).  
 
Most SRF-regulated promoters possess CpG islands and strong H3K4me3 marking 
(Deaton and Bird, 2011; Vavouri and Lehner, 2012). It’s still obscure how H3K4me3 
mark is deposited. To determine whether SRF binding contributes to H3K4me3 
deposition, we measured H3K4me3 levels in CRISPR mutants (Figure 3-10C). 
Interestingly, mutating either the SRF or Ets site can reduce half of Nr4a1 promoter 
H3K4me3 signal. This indicates that SRF binding alone is insufficient for optimal 
H3K4me3 marking; the formation of ternary complex at basal level is required for 
optimal H3K4me3 marking. Studies have shown that histone modification is associated 
with the active ternary complex, possibly by directly or indirectly recruiting histone 
modifiers (Esnault et al., 2017). And the other half of H3K4me3 signal might depend on 
other mechanisms. For example, CpG-binding proteins can bind to CpG islands and 
recruit methyltransferase to promote H3K4me3 marking (Thomson et al., 2010).   
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Consistent with the ChIP data, mutating either the SRF or Ets site significantly impaired 
Nr4a1 gene induction (Figure 3-10D). This indicates that the potent gene induction 
requires forming an active ternary complex. Although loss of ternary complex reduced 
more than 70% of maximal transcription, there was still more than 20-fold gene 
induction. This suggests that other transcription factors may also contribute to Nr4a1 
transcription. For example, MAPK-activated CREB may independently induce the 
transcription of Nr4a1. Thus, by investigating the SRF target, Nr4a1, we demonstrated 
that SRF could bind and recruit TCF to optimize H3K4me3 level and gene induction. 
 
Ternary Complex at the Egr3 Enhancer Stabilizes SRF Binding and Promotes 
Transcription  
To assess whether TCF-SRF interaction also regulates enhancer function, we mutated 
the Ets site at the Egr3 enhancer, which has the strongest SRF peak on chromosome 
14 (Figure 3-11A, Figure 3-6B). Interestingly, the Egr3 enhancer has the same SRF site 
and TCF site as the Nr4a1 promoter. But they have different motif spacing. Because 
Egr3 has a second SRF site at the promoter peak, which might be redundant or 
dependent on the enhancer SRF site, we individually mutated the promoter and 
enhancer sites in immortalized macrophages using CRISPR.  
 
Consistent with our hypothesis that TCF can stabilize SRF binding, mutating the 
enhancer Ets site compromised the binding of SRF to the Egr3 enhancer. Mutating the 
enhancer Ets site has similar effects as mutating the enhancer SRF site (Figure 3-11B). 
Thus, like Nr4a1 promoter, the Egr3 enhancer might also possess a ternary complex 
formed by the cooperative binding of SRF and TCF. However, there is still about one 
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third of residual SRF binding at the Egr3 enhancer in the absence of the enhancer SRF 
site. Two likely explanations may account for the residual SRF binding. First, there may 
be another cryptic SRF site at the Egr3 enhancer. Although we found another weaker 
SRF motif, its mutation did not affect SRF binding or Egr3 transcription (data not 
shown). It is possible that these two enhancer SRF sites are redundant to each other, 
but the stronger one is more critical. Second, promoter SRF binding might contribute to 
the residual enhancer SRF binding through promoter-enhancer interaction.  
 
Likewise, mutating the promoter SRF site did not affect SRF binding at the enhancer 
(Figure 3-11C). This indicates that the enhancer SRF binding is independent of the 
promoter SRF site. Conversely, mutating the enhancer SRF site or Ets site did not 
affect promoter SRF binding; only mutating the promoter SRF site impaired promoter 
SRF binding. Thus, SRF binding at the promoter and enhancer are independent of each 
other. Probably because there is only one SRF site at the promoter, loss of SRF binding 
was greater at the promoter than that at the enhancer. It is also possible that the 
promoter SRF site, rather than the enhancer SRF site, is essential for promoter-
enhancer looping. While mutating the enhancer SRF site still allows for promoter-
enhancer interaction and the detection of SRF binding at the enhancer, mutating the 
promoter SRF might abolish promoter-enhancer interaction and therefore prevent 
detecting SRF binding at the promoter.  
 
SAP1 binding was similarly curtailed by mutating either the SRF or Ets site at the Egr3 
enhancer (Figure 3-11D). Therefore, like the Nr4a1 promoter, TCF binding at the Egr3 
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enhancer is also dependent on SRF. Furthremore, loss of the promoter SRF site did not 
affect TCF binding at the enhancer. This again confirms that ternary complex formation 
at the enhancer is independent of the promoter SRF site.  
 
Mutating either the enhancer SRF site, TCF site, or promoter SRF site reduced more 
than 70% of the maximal Egr3 transcription (Figure 3-11E). The reduced gene induction 
suggests that ternary complex formation at the enhancer is critical for Egr3 gene 
induction. Because the enhancer and promoter mutation exhibit similar loss of gene 
induction, both the enhancer and promoter may be required for Egr3 induction, possibly 
by promoter-enhancer looping. However, none of these mutants reduced the gene 
expression to basal level. The residual 30% of transcription might be explained by the 
activity of the promoter or enhancer alone. It is also likely that other lipid A-activated 
transcription factors can contribute to Egr3 transcription. For example, we found that 
CREB binds to a strong CREB motif on the Egr3 promoter in CREB ChIP-seq data 
(data not shown). This suggests that SRF and CREB may act independently to promote 
the transcription of Egr3.   
 
We did not detect any change of histone marks for active enhancer (H3K27ac) or active 
promoter (H3K4me3) in any of these mutants (data not shown). This might result from 
the redundant roles of promoter and enhancer. This might also imply that histone mark 
deposition is dependent on gene-specific mechanisms at Egr3.   
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Promoter SRF-TCF Cassette Is Correlated with Robust and Ubiquitous 
Transcriptional Induction   
To understand the cell-specific binding patterns of SRF, we compared the SRF ChIP-
seq data from five different cell types: BMDMs, 3T3 fibroblasts, cortical neurons, HL-1 
cardiac muscle cells, and C2C12 myocytes (Esnault et al., 2014; Kim et al., 2010; He et 
al., 2011). Because we have more confidence in identifying targets regulated by 
promoter peaks than enhancer peaks, we first compared SRF promoter peaks in 
different cell types. When comparing all promoter peaks, we found up to 78 unique 
promoter peaks in each cell type, but not all of them may be regulated by direct or 
functional binding (Figure 3-12A, left). To enrich the functional sites, we further 
compared the strong peaks combining strong motifs. This revealed only fewer than 5 
unique promoter peaks in each cell type. These promoter peaks are generally weaker 
peaks and lack CpG islands at promoters (Figure 3-12A, right). And many of these 
promoters regulate cell-specific genes. For example, one neuron-specific SRF promoter 
peak is associated with Pou3f4, a gene encoding a neuron-specific transcription factor. 
It is likely that this small subset of cell-specific promoter SRF peaks tends to form stable 
nucleosomes and requires chromatin remodeling initiated by cell-specific transcription 
factors.  
 
All these five cell types share 41 SRF promoter peaks containing strong SRF motifs. 
These 41 promoters include seven SRF targets bearing promoter SRF-TCF cassettes. 
Only one SRF target, Glipr1, is not among these 41 promoters. Glipr1 lacks a CpG-
island promoter. It’s likely that the SRF binding to Glipr1 promoter requires chromatin 
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remodeling maintained by another macrophage-specific transcription factor. Because 
SRF predominantly binds to CpG-island promoters, which are constitutively accessible 
without the requirement of chromatin remodeling, SRF can ubiquitously bind to these 
promoters in many cell types. 
 
Next, we compared published transcriptional data using different activators of SRF in 
three cell types: lipid A stimulation in BMDMs; serum stimulation in 3T3 fibroblasts; and 
KCl depolarization in neurons (Tong et al., 2016; Esnault et al., 2014; Kim et al., 2010). 
All these stimuli strongly induced the MAPK-TCF pathway. Serum stimulation also mildly 
activates Rho-actin pathway and MRTF. When we compared the 41 genes with strong 
promoter SRF binding and strong SRF motifs, we found only six genes induced more 
than five fold in all cell types (Figure 3-12C). All of them are the SRF targets identified in 
the lipid A response (Figure 3-4A). This suggests that the defined promoter SRF-TCF 
cassette is functional in different cell types and may be essential for the ubiquitous gene 
induction. Therefore, by embedding the conserved TCF-SRF cassettes in accessible 
CpG-island promoters, the SRF-TCF ternary complex can bind ubiquitously in different 
cell contexts and promote robust and transient transcriptional activation by different 
stimuli. 
 
Discussion  
By carefully documenting the motif characteristics of SRF peaks associated with SRF 
targets, we discovered that the MAPK-TCF pathway selectively regulates a small subset 
of SRF targets through a unique promoter SRF-TCF cassette. This strict motif 
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requirement refined the model of the combinatorial regulation by multiple transcription 
factors. This study also demonstrated that our gene-centric method has the potential to 
uncover the mechanistic details of transcriptional regulation.  
 
By comparing the transcriptional induction, motif strength, and binding strength in well-
defined gene sets, we were able to separate the direct and functional binding events 
that contribute to transcription. The correlation between strong binding, strong SRF 
motifs, and strong conservation at primary response genes suggest that SRF activity 
requires direct binding to a strong SRF motif. The differential CpG content and motif 
conservation at promoters and enhancers indicate that SRF binds to promoters and 
enhancers with different mechanisms to differentially regulate gene expression. 
Previous studies have found that SRF can regulate ubiquitously expressed genes 
through promoters, and SRF can regulate expression of cell-specific and stimulus-
specific transcription through enhancers (Sullivan et al., 2011). Because many cell-
specific and stimulus-specific genes evolved later than genes regulating development 
and essential cellular functions, these cell-specific and stimulus-specific enhancers 
might not be as conserved as promoters.  
 
Because MAPK-induced SRF targets are relatively few, and there are many studies on 
individual SRF targets, we were able to scrutinize each SRF target. By comparing their 
features of motif, peak strength, and expression, we found unique patterns emerged. 
We discovered that promoter-regulated SRF targets share a strict SRF-TCF cassette. 
Although previous studies have examined individual SRF targets and identified 
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consensus SRF motifs using the site selection method and de novo motif discovery, we 
found that the SRF-TCF targets require even stricter motif sequences (Pollock and 
Treisman, 1990; Sullivan et al., 2011; Esnault et al., 2014;). The strict rules explain why 
the defined SRF-TCF targets are highly selective and rare in the mouse genome. 
Besides the eight SRF targets, the characterized promoter SRF-TCF cassette only 
exists in 9 of 21013 promoters that lack SRF binding. Furthermore, the SRF-TCF 
cassettes of SRF targets are more conserved than those without SRF binding. While 
seven of the eight promoter SRF motifs of SRF targets are conserved, only five of the 
nine promoter SRF motifs lacking SRF binding are conserved. We also found these 
nine SRF motifs lack CpG islands at promoters and probably reside in inaccessible 
chromatin. This suggests that these SRF-TCF cassettes lacking SRF binding might 
evolve later and require recruiting chromatin-remodeling complexes by cell-specific or 
stimulus-induced transcription factors.  
 
Besides the eight SRF targets, we found another 37 genes containing strong promoter 
SRF binding and strong SRF motifs. At least one third of them are regulated by another 
cofactor of SRF, MRTF. Interestingly, some genes can be activated by either TCF or 
MRTF. Because TCF and MRTF can competitively bind to a common interface at SRF, 
these genes might be controlled by the integrated signals from both pathways (Murai 
and Treisman, 2002; Zaromytidou et al., 2006; Gualdrini et al., 2016). In contrast, some 
genes can be activated by only one pathway. These genes might employ a selective 
mechanism to prevent the interference of another pathway. While SRF targets are 
sensitive to any MAPK-TCF activator, many MRTF targets do not respond to all types of 
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MRTF stimuli. For example, a weak activator of MRTF, serum stimulation, failed to 
activate twelve genes that were inducible by cytochalasin D in the same cell type. The 
differential responses to MRTF activators indicate that different stimuli can selectively 
regulate MRTF through yet unknown mechanisms. Besides MRTF-regulated SRF 
targets, strong SRF promoter binding and strong motifs also exist at the promoters of 
another 25 genes. There is no evidence supporting their regulation by the SRF-TCF or 
SRF-MRTF pathways. Therefore, their activation might require selective post-
translational modifications, other cofactors of SRF, or collaboration with other 
transcription factors (Posern and Treisman, 2006; Sealy et al., 1997; Watson et al., 
1997).  
 
We also found that SRF targets are unique in their exceptionally strong SRF binding.  
Several mechanisms can possibly explain this phenomenon. The most likely 
explanation is the supportive role of TCF, which can bind cooperatively with SRF in a 
ternary complex and stabilize SRF binding. By CRISPR mutation experiments, we found 
that TCF can enhance SRF binding not only at promoters but also at enhancers. Three 
strongest enhancer peaks with SRF and TCF motifs are all in the vicinity of previously 
identified SRF targets. Therefore, these SRF-TCF motifs at enhancers might also 
possess a ternary complex that regulates transcriptional induction by lipid A.  
 
Besides the supportive role of TCF, the proximate CREB binding might also contribute 
to the strong binding of SRF. It is interesting to clarify whether CREB can promote SRF 
binding through direct or indirect mechanisms. It is possible that CREB binding can 
  102 
bend the DNA or exclude nucleosomes to increase accessibility for ternary complex 
formation. Alternatively, CREB can facilitate SRF binding and transcription by 
participating in a large complex. It has been shown that the active SRF-TCF complex 
can recruit CREB binding protein (CBP), which also interacts with CREB at c-fos 
promoter (Nissen et al., 2001; Ramirez et al., 1997). Because CREB can independently 
recruit CBP, CREB can probably promote the interaction between CBP and ternary 
complex and assist with basal transcriptional machinery assembly. CREB is also known 
to regulate several SRF targets (Ahn et al., 1998; Herndon et al., 2013; Vialou et al., 
2012; Ramanan et al., 2005). Because most SRF targets are involved in key cellular 
functions including cell proliferation, cell cycle regulation, apoptosis, cell growth, and 
metabolism, they might require stringent regulation by more than one mechanism. In 
addition to SRF-TCF regulation, CREB can add another layer of regulation to SRF 
targets, refining the expression pattern for stimulus-specific responses. And by 
integrating different intracellular and extracellular signals, the combination of SRF and 
CREB regulation may sensitize the cellular response to environmental changes.  
 
By mutating the SRF and Ets sites at the promoter of Nr4a1, we confirmed that TCF 
supports the strong binding of SRF. While SRF can bind by itself, TCF alone cannot 
bind to DNA. This suggests that SRF might be able to recruit TCF on the Nr4a1 
promoter. Although many studies showed that SRF could recruit TCF, there is also 
evidence indicating that TCF can recruit SRF to form a ternary complex (Treisman et al., 
1992; Latinkic et al., 1996).  It is likely that the subtle sequence differences in TCF 
members can affect the interaction with SRF and DNA. DNA context can also affect 
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SRF and TCF interaction. For example, both SAP1 and Elk-1 contain C-terminal 
inhibitory sequences that prevent the autonomous binding to DNA (Treisman et al., 
1992). By mutating SRF and Ets sites, we found that ternary complex is also required 
for the optimal H3K4me3 marking at the Nr4a1 promoter. The underlying mechanism is 
still unclear. It is likely that the SRF-TCF ternary complex can recruit histone modifiers 
(Esnault et al., 2017). It is also likely that the loss of ternary complex binding can affect 
the nucleosome structure and histone modifications.  
 
By CRISPR mutation experiments, we confirmed that TCF can facilitate SRF binding at 
the Egr3 enhancer. Moreover, Egr3 induction depends on both the promoter and 
enhancer SRF sites. Similar to Egr3, another two Egr family members, Egr1 and Egr2, 
also possess two SRF peaks upstream of the TSS. It will be interesting to investigate 
whether these two peaks are redundant or interdependent to each other. Because Egr1, 
Egr2, and Egr3 belong to the same family and share similar patterns of SRF binding, 
their regulation by SRF might depend on similar mechanisms. However, comparing to 
Egr1 and Egr2, Egr3 is distinct in at least three aspects. First, while Egr1 and Egr2 have 
two SRF promoter peaks, Egr3 has one promoter peak and one enhancer peak. 
Second, Egr3 has fewer copies of SRF motifs than Egr1 and Egr2. Third, although all 
three genes exhibit similar transcriptional kinetics after stimulation, Egr3 has a much 
lower expression level than Egr1 and Egr2. The first two differences can possibly 
explain the lower expression level of Egr3. Because both the promoter and enhancer 
are required for the optimal induction and the Egr3 enhancer peak is far from the TSS, 
Egr3 expression may be limited by enhancer-promoter interaction. This can result in 
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less potent transcription than Egr1 and Egr2, which both depend on promoter 
regulation. It is also likely that fewer copies of SRF motifs can lead to lower SRF binding 
affinity to Egr3. But it is also possible that the additional SRF motifs of Egr1 and Egr2 
can enhance transcription by other mechanisms. Because Egr members regulate genes 
of different biological functions, SRF might control the differential expression of different 
family members by altering their motif copies and locations (Poirier et al., 2008; 
O’Donovan et al., 1999).  
 
Interestingly, lipid A-induced SRF targets are the only genes that are inducible by 
different MAPK activators and in different cell types. The robust and ubiquitous 
transcriptional induction of SRF targets probably derives from the combination of CpG-
island promoters and the unique SRF-TCF cassettes. Because CpG-island promoters 
form unstable nucleosomes and are constitutively accessible in all cell types, they allow 
the formation of ternary complex in resting cells, which can rapidly respond to various 
environmental stimuli through MAPK pathway activation.  
 
Thus, by revisiting a classical model of combinatorial regulation using a gene-centric 
method, we revealed strict motif rules that selectively regulate the SRF-TCF targets. 
Because SRF lacks have any functionally redundant family member and interacts with 
only one cofactor at a time, it represents a relatively simple model of combinatorial 
regulation. But the strategy in our study has demonstrated the potential to answer more 
complicated questions. In future studies, we can use this strategy to investigate how 
different transcription factors act in concert to induce gene transcription in more 
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complicated combinatorial regulation models involving more factors. We can also use 
this strategy to explore and compare the regulatory mechanisms of different 
transcription factor family members. And this will deepen our understanding of the 
mechanisms and underlying biological significance that account for the selective 
transcriptional activation by different environmental stimuli. 
 
Materials and Methods 
Cell Culture and Reagents 
Bone marrow cells were isolated from 6- to 10-week-old C57BL/6 male mice. They were 
incubated in medium containing M-CSF for six days for macrophage differentiation. 
Bone marrow-derived macrophages were stimulated with 100ng/ml lipid A (Sigma 
L6895) for 0, 15, 30, 60, and 120min before cross-linking for ChIP experiments. J2 
virus-immortalized macrophages were also from C57BL/6 mouse. Immortalized 
macrophages were incubated in medium containing 0.5% fetal bovine serum overnight. 
The next day, they were stimulated by 100ng/ml lipid A in media with 20% fetal bovine 
serum.  
 
Chromatin Immunoprecipitation and ChIP-seq Library Preparation 
After stimulation, 40 million bone marrow-derived macrophages were cross-linked with 
1% formaldehyde (Fisher, PI-28908). Nuclei pellets were isolated and sonicated using 
Misonix 3000 sonicator to fragments between 200bp to 1000bp. Chromatin lysate was 
incubated with SRF antibody (Santa Cruz, sc-335), SAP1 antibody (Santa Cruz, sc-
13030), or H3K4me3 antibody (Millipore, 07-473) overnight. The immune complex was 
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pulled down by Protein G Dynabeads (Invitrogen, 10004D) and washed for four times. 
The purified immune complex was incubated with proteinase K (ThermoScientific, 
EO0491) at 60°C overnight for reverse cross-linking and protein digestion. IP DNA was 
purified by phenol-chloroform (Sigma, P3803). DNA concentration was quantified by 
Qubit kit (Thermo Fisher, Q32854). ChIP-seq library was prepared using KAPA LTP 
library preparation kit (KK8500) following the manufacturer’s instructions.  
 
ChIP-seq Read Mapping and Processing  
ChIP-seq library samples were sequenced on Illumina HiSeq 2000 platform. Single-end 
50bp reads were aligned to mouse mm9 genome using Bowtie2. Unique mapped reads 
were kept for peak calling using HOMER (Heinz et al., 2010) with enrichment over input 
and FDR less than 0.01. Non-specific peaks were eliminated by comparing with SRF 
ChIP-seq data from SRF KO macrophages. Peak read density was calculated by 
HOMER peak annotation function and heat maps were generated using Java TreeView 
software. SRF peaks were annotated as promoter peaks if they are within -600bp to 
+250bp relative to TSS. CpG content is calculated by dividing the number of observed 
CpG by the number of expected CpG. Promoter region is defined as -500bp to +150bp 
relative to TSS.  
 
Chromatin RNA Extraction, RNA-seq Library Preparation and Data Analysis 
See Chapter 2 EXPERIMENTAL PROCEDURES.  
 
Motif Analysis and Conservation Analysis 
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SRF, TCF, and CREB motifs were searched using TRANSFAC and JASPAR 
transcription factor data base by Pscan (Wingender et al., 1996; Mathelier et al., 2016; 
Zambelli et al., 2009). Promoter region is defined as -500bp to +150bp relative to TSS. 
The best SRF motif identified by motif M00186 was used for analysis of each SRF peak.  
Ets motifs (M00032, M00074, M00007, M00025, MA0080.3, MA0081.1, MA0098.2, 
MA0028.1, and MA0076.2) were used to search the nearest Ets site near SRF motif. 
CREB motif M00039 was used to find the best CREB motif in promoter or enhancer 
peaks. 
 
Conservation score is quantified using UCSC PhastCons placental mammal data 
(Siepel et al., 2005). Conservation score is quantified as the average PhastCons score 
over a 10bp SRF motif. The best SRF motif of each region was used for conservation 
analysis. Enhancer SRF motifs in the mouse genome were identified using HOMER 
findMotifsGenome.pl function. Strong motifs were identified with SRF motif score 
(M00186) greater than 0.89. 
 
CRISPR 
J2 virus-immortalized macrophages were diluted and seeded in 96-well plates to obtain 
single cell colonies. Single cell-derived colony was expanded for CRISPR experiment. 
Single guide CRISPR sequences targeting transcription factor binding sites were 
designed using MIT CRISPR Designer (http://crispr.mit.edu/). They were cloned into 
lentiviral vector lentiCRISPRv2 (Addgene, 52961), which expresses both Cas9 and 
guide RNA. Lentiviral vectors and lentiviral packing plasmids psPAX2 (Addgene, 12260) 
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and pMD2.G (12259) were transfected into 293T cells. Lentiviral media were collected 
36hr and 60hr after transfection. One million single cell-derived macrophages were 
plated in 6-well plates. Each well was incubated with 4ml of lentiviral medium and 
centrifuged at 2000rpm for 1.5 hours. Two spin infections were performed. Three days 
after the second spin infection, macrophages were cultured in medium containing 
12.5ug/ml puromycin for seven days. Puromycin selection media were replaced every 
two days. Puromycin-resistant macrophages were scraped, diluted, and plated into 
single cells in 96-well plates. Single cell colonies were expanded for 2 weeks. Cells 
were lysed and protein is digested by proteinase K at 55°C overnight. Genomic DNA is 
precipitated by isopropanol. DNA pellets were washed with 70% ethanol and dissolved 
in water. Primers targeting the transcription factor sites were used to select mutant 
clones. The region flanking the mutation sites of candidate clones were PCR amplified 
and sent for Sanger sequencing. Two mutants for each CRISPR guide RNA were 
selected for qRT-PCR and ChIP experiments.  
 
RNA extraction and qRT-PCR  
Two million cells were lysed in TRI reagent (Molecular Research Center, TR118). RNA 
was extracted using Qiagen RNeasy kit following the manufacture’s instructions. 1ug 
RNA was used to synthesize cDNA. Levels of cDNA were quantified by qPCR using 
BioRad CFX384 Real-Time PCR machine.   
 
Accession Number 
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RNA-seq, ChIP-seq, and ATAC-seq data were deposited in Gene Expression Omnibus 
(GEO) database. BMDM chromatin RNA-seq, SRF ChIP-seq and ATAC-seq are under 
session number GSE67357. H3K27ac ChIP-seq data are under session number 
GSE38379. 3T3 fibroblast RNA-seq and ChIP-seq data are under session number 
GSE45888. Neuron SRF ChIP-seq data are under session number GSE21161. C2C12 
SRF ChIP-seq data is under session number GSE36024. HL-1 SRF ChIP-seq data is 
under session number GSE21529. 
 
 
Figure Legends 
Figure 3-1. General Features of SRF ChIP-Seq in Lipid A-Activated Macrophages 
Bone marrow-derived macrophages were stimulated with lipid A for 0, 15, 30, 60, and 
120 min. Samples were collected for SRF ChIP-seq experiments. (A) The heat map 
shows the read density of SRF ChIP-seq peaks in a 6-kb window, centered in peaks 
called in at least one sample (by HOMER, false discovery rate <0.01). Peaks are ranked 
by the average peak score. The color indicates the read value. (B) The pie chart 
displays the genomic distribution of 718 reproducible peaks. Promoter region is defined 
as -500 to +150 bp relative to the TSS. (C) The genomic distribution of SRF ChIP-seq 
peaks is compared with the distribution of different genomic regions. (D) The CpG 
content of 166 promoters with SRF binding (in red) is compared with 21168 promoters 
(in black) in the mouse genome. The y-axis shows CpG content of promoters, which 
equals to the number of observed CpG divided by the number of expected CpG. The x-
axis shows the percent of promoters in each category. The table compares the CpG 
content between SRF-regulated promoters and all promoters. (E) The CpG content of 
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552 SRF enhancer peaks (in red) is compared with 26434 enhancers with H3K27ac 
peaks (in black). The y-axis shows the CpG content, which equals to the number of 
CpG divided by the number of expected CpG in a 395-bp window. The x-axis shows the 
percent of enhancers in each category. The table compares the CpG content between 
SRF-regulated promoters and all promoters. 
 
Figure 3-2. Identify SRF Targets by RNA-seq and ChIP-seq   
(A) The heat map shows log2-transformed expression levels of eight SRF targets. 
Macrophages were stimulated by lipid A with 5 min intervals in the first hour including a 
2 hr stimulation. The blue shade indicates the expression level. The blue and red heat 
map shows the fold change of each time point relative to the previous time point. The 
CpG column shaded in brown indicates genes with CpG-island promoters 
(observed/expected CpG ratio is greater than 0.6). The MAPK column in blue indicates 
genes inhibited by MAPK inhibitors (ERK inhibitor PD0325901; p38 inhibitor BIRB0796) 
by at least three fold. (B) The left panel shows the genome browser snapshots of SRF 
binding at the promoters of six SRF targets: Egr1, Egr2, Dusp5, Fos, Zfp36, and Nr4a1. 
The right panel shows SRF binding to distal regions of two SRF targets (Btg2 and Ier2), 
which overlap with H3K27ac enhancers. The red arrow indicates the TSS and the 
direction of transcription.  
 
Figure 3-3. Characterize SRF Peaks by Peak Strength and Motif Strength  
(A) The left scatter plot displays the peak score of promoter peaks (x-axis) and the motif 
score by TRANSFAC transcription factor database (y-axis) of 132 primary response 
  111 
genes. The right scatter plot shows the peak score and motif score of other gene 
classes: secondary response genes, 2- to 10-fold induced genes, not induced genes, 
and low expression genes. The horizontal dashed line indicates the motif score 
threshold of 90. The vertical dashed line indicates the peak score threshold of 10. (B) 
Tables display the number and percent of promoters divided by motif score and peak 
score in five gene classes. (C) The line graph shows the conservation scores of SRF 
sites for SRF peaks at primary response genes (left), all promoters (middle), and 
enhancer sites (right). Conservation score is quantified as the average score spanning 
the 10-bp SRF motif using UCSC PhastCons data. Promoter SRF sites and enhancer 
SRF sites with binding are identified by Pscan. Strong SRF motifs at enhancers without 
binding are predicted by HOMER.  
 
Figure 3-4. SRF Targets Share a Unique Promoter SRF-TCF Cassette  
(A) The table lists SRF motif, TCF motif, and motif spacing at the promoters of six SRF 
targets in primary response genes and another two SRF targets in other gene classes. 
(B) The scatterplot shows the fold change of nascent transcripts induced by lipid A (x-
axis) and the percent of maximal expression in the presence of MAPK inhibitors (ERK 
inhibitor PD0325901 and p38 inhibitor BIRB0796). The horizontal dashed line indicates 
the expression threshold of 33%. The vertical dashed line indicates the fold change 
threshold of 5. SRF targets in primary response genes are highlighted in red. Another 
two SRF targets, Glipr1 and Fosb, are labeled in the right bottom square. (C) The heat 
map shows nascent transcript expression of six SRF targets in primary response genes 
and genes in other classes that also have strong SRF motifs and strong SRF binding at 
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promoters. Normalized expression by RPKM is shown in blue scale. The fold change 
relative to the previous time point was shown in blue to red scale. MAPKi column in blue 
indicates genes sensitive to MAPK inhibition.     
 
Figure 3-5. Identify Promoters Containing Defined SRF-TCF Cassettes and 
Lacking SRF Binding 
(A) The table lists SRF motif, TCF motif, locations of motifs, motif spacing, and CpG 
content of nine genes in the genome that contain the defined promoter SRF-TCF 
cassettes. CpG content equals the number of CpG divided by the number of expected 
CpG in promoter. (B) The dot plot displays the promoter CpG content of eight SRF 
targets (in red) and nine genes with promoter SRF-TCF cassettes lacking SRF binding 
(in black). The dotted horizontal line indicates the CpG obs/exp threshold of 0.6. (C) The 
dot plot compares the levels of H3K4me3 (in green) and ATAC-seq signal (in black) 
between eight SRF targets (left) and nine genes with promoter SRF-TCF cassettes 
lacking SRF binding (right). The levels of H3K4me3 ChIP-Seq and ATAC-seq are 
evaluated by RPKM of the called peaks. The dotted horizontal line indicates the RPKM 
threshold of 2. (D) The dot plot compares the position of promoter SRF motif relative to 
the TSS between eight SRF targets (in red) and nine genes with promoter SRF-TCF 
cassettes lacking SRF binding (in black). The dotted horizontal lines indicate position 
-410 and +1 relative to the TSS.  
 
Figure 3-6. Interrogate the Potent SRF Binding at SRF Targets  
(A) The scatterplot shows SRF peak score (x-axis) and SRF motif score quantified by 
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TRANSFAC database (y-axis) at all promoters. The grey horizontal dashed line 
indicates the motif score threshold of 89.5. The vertical dashed line indicates the peak 
score threshold of 10 (left, used for strong SRF binding) and 67 (right, used for top 15 
promoter peaks). Eight SRF targets are highlighted in red. Top 15 peaks are highlighted 
in blue. (B) Genome browser snapshots display six chromosomes containing SRF 
peaks of SRF targets and Egr3. (C) Motif analysis comparing the strong motifs with 
peak score greater than 30 and strong motifs with peak score lower than 30. The p 
value (in red) of the enriched motifs is quantified by Pscan. (D) The scatterplot 
compares CREB and SRF motif spacing identified by Pscan (x-axis) and motif score (y-
axis) at promoters with strong SRF binding and motifs. The grey dashed horizontal line 
indicates the CREB motif score threshold of 0.87. The grey dashed vertical line 
indicates the SRF-CREB motif spacing threshold of 70bp. Eight SRF targets are 
highlighted in red. Two SRF targets (Fos and Zfp36) outside the top left square are 
labeled. Another two top promoter peaks (Srf and Bcl2l12) with strong motifs are also 
labeled. (E) The table compares the eight promoters at the top left square in (D) by their 
CREB motif score, SRF-CREB motif spacing, CREB ChIP-seq peak score, and SRF 
ChIP-seq peak score. (F) Promoter sequences of six SRF targets, which rank among 
top 15 strongest promoter peaks. Position relative to the TSS is shown on left. SRF 
sites are in red; TCF sites are in blue; and CREB sites are in green. 
 
Figure 3-7. Strong Promoter SRF Peaks Possess Proximate CREB Binding and 
Multiple SRF Motifs  
(A) The table compares SRF targets and another two genes (Srf and Bcl2l12) by the 
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number of SRF site, minimal motif spacing between SRF sites, CREB site near SRF 
site, TCF site near SRF site, and SRF peak score. (B) Promoter sequences of Egr1 and 
Egr2, which have multiple SRF sites and TCF sites. Position relative to the TSS is 
shown on left. SRF sites are in red; TCF sites are in blue; and CREB sites are in green.  
 
Figure 3-8. SRF-TCF Motifs at Enhancer SRF Peaks Correlate with SRF Targets  
(A) The scatterplot shows SRF peaks score (x-axis) and SRF motif score quantified by 
TRANSFAC database (y-axis) at enhancer peaks. Enhancer SRF peaks containing Ets 
motifs within 20bp of SRF motifs are in blue. Enhancer SRF peaks containing CREB 
motifs within 70bp of SRF motifs are in yellow. Enhancer SRF peaks containing both 
Ets motifs within 20bp of SRF motifs and CREB motifs within 70bp of SRF motifs are in 
red. The horizontal dashed line indicates the motif score threshold of 89.2. The vertical 
dashed lines indicate the SRF ChIP-seq peak score threshold of 10 (left, for strong 
peaks) and 88 (right, for top 25 strongest enhancer peaks). The closest genes of 25 
strongest enhancer peaks in top right square are labeled: two peaks in red represent 
Btg2 and Ier2; one peak in blue represents Egr3; two peaks in yellow represent Junb 
and Ubald1. (B) Enhancer SRF peak sequences of Btg2, Ier2, and Egr3 are shown. 
Position relative to the TSS is shown on left. SRF sites are in red; TCF sites are in blue; 
and CREB sites are in green. (C) The line graph indicates RNA-seq RPKM values 
measuring the nascent transcript levels of Egr3 stimulated by lipid A in the presence of 
DMSO (in black) control or MAPK inhibitors (in blue).  
 
Figure 3-9. The Role of MRTF in Regulating Promoters with Strong SRF Binding 
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and Strong Motifs 
(A) The bar graphs compare the mRNA expression of Srf induced by 100ng/ml lipid A in 
BMDMs. (B) The bar graph compares mRNA expression of Bcl2l12 stimulated by 2uM 
cytochalasin D (CytoD) in 3T3 fibroblasts. (C) Genome browser snapshots show that 
SRF binding coincides with MRTF binding at the promoter of Srf following serum 
stimulation in 3T3 fibroblasts. (D) The table summarizes genes with strong promoter 
binding and SRF motifs by their responses to cytochalasin D (CytoD) and MRTF binding 
in 3T3 fibroblasts. (E) The scatterplot shows the fold change of nascent transcript 
induced by lipid A in macrophages (x-axis) and the fold change of mRNA induced by 
cytochalasin D (CytoD) in 3T3 fibroblasts (y-axis) for genes with strong promoter 
binding and strong SRF motifs. Eight SRF targets are in red. Genes with inducible 
MRTF binding by serum stimulation are in green. Other genes with strong promoter 
SRF binding and strong motifs are in grey.  
 
Figure 3-10. Evaluate the Roles of the Ternary Complex at the Nr4a1 Promoter by 
CRISPR  
Bar graphs show SRF binding (A), SAP1 binding (B) or H3K4me3 (C) at the Nr4a1 
promoter in control, mutant lacking the SRF site (sgSRF), and mutant lacking the TCF 
site (sgTCF). J2 virus-immortalized bone marrow-derived macrophages are stimulated 
with 100ng/ml lipid A and 20% serum. The data shown represent an average of three 
biological replicates. (D) Bar graph shows the fold change of the Nr4a1 mRNA induced 
by 100ng/ml lipid A and 20% serum in immortalized macrophages. The data shown 
represent an average of three biological replicates. Error bars indicate the standard 
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error. **p < 0.01; *p < 0.05; n.s.=not significant.  
 
Figure 3-11. Evaluate the Roles of the Ternary Complex at the Egr3 Enhancer by 
CRISPR 
(A) Genome browser snapshots show the enhancer SRF peak and promoter SRF peak 
of Egr3. The enhancer peak contains one TCF site (in blue) and one SRF site (red). The 
promoter contains one SRF site (in red). Bar graphs show SRF binding at the Egr3 
enhancer (B) or promoter (C) in control, mutant lacking the enhancer SRF site 
(sgEnh_SRF), mutant lacking the enhancer TCF site (sgEnh_TCF), and mutant lacking 
the promoter SRF site (sgPro_SRF). J2 virus-immortalized bone marrow-derived 
macrophages are stimulated with 100ng/ml lipid A and 20% serum. (D) Bar graph 
shows SAP1 binding at the Egr3 enhancer in control, mutant lacking the enhancer SRF 
site (sgEnh_SRF), mutant lacking the enhancer TCF site (sgEnh_TCF), and mutant 
lacking the promoter SRF site (sgPro_SRF). (E) Bar graph shows the fold change of 
Egr3 mRNA induced by 100ng/ml lipid A and 20% serum in immortalized macrophages. 
The data shown represent an average of three biological replicates. Error bars indicate 
the standard error. **p < 0.01; *p < 0.05; n.s.=not significant.  
 
Figure 3-12. Robust Induction of SRF Targets by Different Stimuli in Different Cell 
Types 
(A) The Venn diagram compares all SRF promoter peaks (left) or SRF promoter peaks 
with strong motifs (right) overlapping between 3T3 fibroblasts, BMDMs, cortical 
neurons, HL-1 cardiac muscle cells, and C2C12 myocytes. (B) The table lists cell-
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specific promoter peaks with strong motifs by peak score and promoter CpG content. 
(C) The dot plot compares the induction of 41 genes with strong promoter binding and 
strong motifs in five cell types. Gene induction is quantified by RNA-seq data in different 
cell types. Nascent transcript induction by lipid A in BMDMs is in red. Messenger RNA 
induction by serum stimulation in 3T3 fibroblasts is in green. Messenger RNA induction 
by KCl depolarization in cortical neurons is in blue. The grey vertical dashed line 
indicates the fold change threshold of 5. 
 
 
Table 3-1. List of Genes with SRF Binding or SRF Motifs  
The list shows the Refseq IDs, gene symbols, aliases, and functions of lipid A-induced 
SRF targets, genes with promoter SRF-TCF cassettes lacking binding, and other genes 
mentioned in this article.  
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Figure 3-1. General Features of SRF ChIP-Seq in Lipid A-Activated Macrophages 
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Figure 3-2. Identify SRF Targets by RNA-seq and ChIP-seq   
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Figure 3-3. Characterize SRF Peaks by Peak Strength and Motif Strength  
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Figure 3-4. SRF Targets Share a Unique Promoter SRF-TCF Cassette  
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Figure 3-5. Identify Promoters Containing Defined SRF-TCF Cassettes and 
Lacking SRF Binding 
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Figure 3-6. Interrogate the Potent SRF Binding at SRF Targets  
 
 
 
 
 
 
Fos
Zfp36
Bcl2l12 Srf
0.7
0.8
0.9
1
0 150 300 450
CR
EB
 M
ot
if S
co
re
CREB-SRF Motif Spacing (bp)
Strong binding & Strong motif SRF Targets
A
C D
B
F
Actb
Egr1
Zswim6
Map3k14
Dusp5
Mobkl2a
Bcl2l12
Egr2
Glipr1
Gga1
Nr4a1
Fosb
Srf
Dhfr
Mcl1
Fos
65
75
85
95
0 100 200
Tr
an
sfa
c S
co
re
SRF ChIP-seq Peak Score
Chr19
Chr18
Chr15
Chr14
Chr10
Chr7
Dusp5
Egr1
Nr4a1
Egr3
Egr2 Glipr1
Fosb
p-val
1.924E-40 2.0013E-46
0.0009 0.1834
0.0011 0.4213
0.0026 0.2648
0.0064 0.6863
SRF
CREB
ATF
E2F
STAF
Strong Motif 
& Peak>30 
(n=20)
Strong Motif 
& Peak<30 
(n=26)
10-5 10-2
E
Gene CREB Motif
SRF-CREB 
Spacing
CREB Peak 
Score
SRF Peak 
Score
Egr1 0.926 47 177.6 190.1
Dusp5 0.926 16 119.2 133.7
Egr2 0.959 16 108.6 94.7
Glipr1 1.000 33 77.8 80.1
Nr4a1 0.877 60 64.6 75.5
Fosb 0.992 49 242.4 74.8
Egr4 0.992 16 0.0 14.7
Filip1l 0.992 20 0.0 26.8
TTTGGCCTTATATGGGCACTCACGTCACAGGACGCGCACTCATTCACATAA 
CGCCGGAACCGCGCCGCCCCCCGCGCCCTTGTATGGCCAAAGCTCGCCG
GGCCGTGTGCGTCAGTGGCGCCCCCGCCCCTCTCCATGCGTCACGGAGC 
-250 
-127 
-155 TCTTGGATGGGAGGGCTTCACGTCACTCCGGGTCCTCCCGGCCGGTCCTT
CCATATTAGGGCTTCCTGCTTCCCATATATGGCCATGTACGTCACGGCGGA 
CAGGCCCAGCCCTGTTCCTCAGTCCATATATGGGCAGCGACGTCACGGGT -95 
CTCTGACGTAATTGCTAGGATACCAAACAAACACTGGGCCGCGCTGGCCGA
GCTCCTTATATGGCTAATTGCGTCACAGGAACTCCGGGGAGGGCGGGG 
-326 
CAAGCCATATATGGAGAAGTCCGGTGTAAGTTTCGTGACGTCATGTTCTGC -44 
Dusp5
Nr4a1
Egr1
Egr2
Glipr1
Fosb
SRF site          TCF site        CREB site
  124 
Figure 3-7. Strong Promoter SRF Peaks Possess Proximate CREB Binding and 
Multiple SRF Motifs  
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Figure 3-8. SRF-TCF Motifs at Enhancer SRF Peaks Correlate with SRF Targets  
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Figure 3-9. The Role of MRTF in Regulating Promoters with Strong SRF Binding 
and Strong Motifs 
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Figure 3-10. Evaluate the Roles of the Ternary Complex at the Nr4a1 Promoter by 
CRISPR  
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Figure 3-11. Evaluate the Roles of the Ternary Complex at the Egr3 Enhancer by 
CRISPR 
 
 
 
 
 
 
 
D
0.0
0.3
0.6
0.9
Re
st
Sti
mu
late
d
SR
F 
Ch
IP
%
 o
f I
np
ut
Control
sgEnh_SRF
sgEnh_TCF
sgPro_SRF
Egr3 Enhancer
*
n.s.
n.s.
*
A
B
0.0
0.1
0.2
0.3
Re
st
Sti
mu
late
d
SA
P1
 C
hI
P
%
 o
f I
np
ut
Control
sgEnh_SRF
sgEnh_TCF
sgPro_SRF
Egr3  Enhancer
n.s.
* n.s.
**
0.0
0.5
1.0
1.5
Re
st
Sti
mu
late
d
SR
F 
Ch
IP
%
 o
f I
np
ut
Control
sgEnh_SRF
sgEnh_TCF
sgPro_SRF
Egr3  Promoter
n.s.** **
n.s.
0
25
50
75
Re
st
Sti
mu
late
d
m
RN
A
Fo
ld 
In
du
cti
on Control
sgEnh_SRF
sgEnh_TCF
sgPro_SRF
Egr3
**
E
C
SRF 
ChIP-seq
Egr3
1.5 kb
SRFTCF SRF
Enhancer Promoter
TCACCGGATCCGCTCCTTGTATGGCTCTT           CTGTCCATATATGGGCAG 
  129 
Figure 3-12. Robust Induction of SRF Targets by Different Stimuli in Different Cell 
Types 
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Table 3-1. List of Genes with SRF Binding or SRF Motifs 
 
 
 
 
 
 
 
 
 
 
 
 
Refseq ID Gene Symbol Aliases Function
SRF Targets
NM_010234 Fos D12Rfj1; c-fos; cFos Transcriptional regulator
NM_011756 Zfp36 Gos24; Ttp; TIS11D; Zfp-36; Nup475; TISII; Tis11 RNA binding protein
NM_010444 Nr4a1 NGFIB; Hbr-1; TR3; NP10; Gfrp; Hbr1; NGFI-B; NUR77-
2; NUR77-1; N10; nur77; TIS1; GFRP1; Hmr
Transcriptional regulator
NM_007913 Egr1 Krox24; TIS8; NGFIA; ETR103; NGF1-A; NGFI-A; Zfp-
6; Zif268; A530045N19Rik; Krox-1; Egr-1; Krox-24; 
Zenk; egr
Transcriptional regulator
NM_010118 Egr2 Egr-2; NGF1-B; Zfp-25; Zfp-6; Krox-20; Krox20 Transcriptional regulator
NM_001085390 Dusp5 Gm337 Signaling molecule
NM_008036 Fosb - Transcriptional regulator
NM_028608 Glipr1 mRTVP-1; RTVP-1; 2410114O14Rik; RTVP1 Tumor suppressor
NM_007570 Btg2 AA959598; APRO1; Pc3; TIS21 Transcriptional regulator
NM_010499 Ier2 Ch1; Pip92; AI317238 Transcriptional regulator
NM_018781 Egr3 Pilot Transcriptional regulator
NM_207138 Olfr149 MOR224-8; M31 G-protein-coupled receptor
NM_007621 Cbr2 MLCR Enzyme
NM_153520 Opalin Tmp10; Tmem10 Transmembrane protein
NM_183031 Gpr183 Ebi2 Signaling molecule
NM_019418 Tnfsf14 LIGHT; HVEML; Tnlg1d; LTg; Ly113; HVEM-L Cytokine
NM_023275 Rhoj TC10L; TCL; 1110005O19Rik; AW210585; Arhj Signaling molecule
NM_009509 Vil1 Vil Signaling molecule
NM_008288 Hsd11b1 - Enzyme
NR_033528 Olfr75-ps1 V1; Olfr75; MOR135-20 G-protein-coupled receptor
NM_029410 Bcl2l12 Bcl2-L12; 2810475P17Rik; 5430429M05Rik; Bcl-L12 Anti-apoptotic factor
NM_020493 Srf AW049942; AW240594 Transcriptional regulator
NM_028810 Rnd3 2610017M01Rik; AI661404; Rhoe; Arhe Signaling molecule
NM_008562 Mcl1 AW556805; Mcl-1 Anti-apoptotic factor
NM_145929 Gga1 4930406E12Rik; AW209092; AU016030 Protein trafficking regulator
NM_010049 Dhfr AI662710; AA607882; 8430436I03Rik; AW555094 Enzyme
NM_007393 Actb E430023M04Rik; Actx; beta-actin Cytoskeleton
NM_145456 Zswim6 2900036G02Rik; mKIAA1577 Metal ion binding
NM_172457 Mobkl2a Mob3a; A630029F06; AV218468; 5330417K06Rik Metal ion binding
NM_016896 Map3k14 aly; Nik Signaling molecule
NM_020596 Egr4 pAT133; NGFIC; NGF1-C; NGFI-C Transcriptional regulator
NM_001177871 Filip1l Doc1; 4631422O05Rik Signaling molecule
NM_008416 Junb - Transcriptional regulator
NM_145359 Ubald1 1500031H01Rik; Fam100a; BC013706 Unkonwn
SRF-TCF Cassettes without Binding
Other Genes
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A balanced mammalian immune system is essential for host defense and homeostasis 
(Kotas and Medzhitov, 2015). Inefficient immune activation can cause susceptibility to 
cancer and pathogen infection. Over-activation of the immune system can cause 
allergy, autoimmunity, and chronic inflammatory diseases such as Crohn’s diseases 
and rheumatoid arthritis (Eberl, 2016; Takeuchi and Akira, 2010). Novel therapies based 
on immune discoveries have proved to show efficacy in treating cancer and other 
diseases (Daniyan and Brentjens, 2017). To develop novel therapeutics for immune-
related diseases, it is essential to understand the mechanisms regulating immune 
responses.  
 
Upon pathogen infection, the innate immune cells often act as the first line of host 
defense. They can recognize pathogen components and damaged cell components by 
various pattern recognition receptors including Toll-like receptors (TLRs), RIG-I-like 
receptors (RLRs), and nucleotide-binding oligomerization domain-like receptors (NLRs) 
(Brubaker et al., 2015; Takeuchi and Akira, 2010). Pattern recognition receptor 
activation will trigger many downstream pathways including MAPK, NFκB, IRF, and 
PI3K. This signal cascade eventually leads to the transcriptional activation of thousands 
of pro-inflammatory genes and the production of antibacterial peptides, cytokines, and 
chemokine, which in turn attract adaptive immune cells and initiate the adaptive immune 
response. Activation of innate immune cells is a highly coordinated process that 
requires the precise regulation at transcriptional, post-transcriptional, translational, and 
post-translational steps. Because transcription acts as the first step for the production of 
inflammatory molecules in the innate immune response, we decided to dissect the 
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transcriptional cascades of a classical pattern recognition receptor: Toll-like receptor 4 
(Li and Biggin, 2015; Vogel and Marcotte, 2012).  
 
Although different stimuli can induce discrete subsets of pro-inflammatory and anti-viral 
genes, they activate innate immune cells through many common signaling pathways 
and transcription factors. The stimulus-specific induction of inflammatory genes through 
common regulators demands using selective gene regulatory mechanisms. While 
studies on inflammatory diseases often identify only a few cytokines and chemokines 
responsible for pathogenesis, it is difficult to inhibit them selectively. Chemical inhibitors 
generally target kinases and can affect many downstream genes. Antibody injection can 
selectively inhibit cytokines or chemokines, but it can lack selectivity for the 
inflammation sites and elicit systematic side effects. To develop more effective and 
selective therapies to treat inflammatory diseases, it is essential to understand both the 
common and gene-specific regulatory mechanisms controlling key inflammatory genes 
during inflammation.  
 
To pursue our long-term goal to understand the selective regulatory mechanisms in the 
innate immune response, we started by studying a key pro-inflammatory gene that 
requires tight and selective regulation: Il12b. In Toll-like receptor 4 (TLR4) 
transcriptional cascades, Il12b is potently and selectively induced by the NFκB family 
member c-Rel (Sanjabi et al., 2005). Il12b induction is also optimized by many other 
transcription factors binding to its promoter and enhancer (Zhou et al., 2007; Bradley et 
al., 2003). Besides transcription factors, Il12b also requires stimulus-induced chromatin 
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remodeling at the promoter. The chromatin regulation of Il12b precedes the binding of c-
Rel and adds an additional layer of transcriptional regulation (Weinmann et al., 2001; 
Weinmann et al., 1999). Owing to the emerging next-generation sequencing 
technologies, we can apply our knowledge of Il12b regulation to whole transcriptome 
studies and investigate similar or different regulatory strategies. We found that 
chromatin remodeling also controls the induction of many late primary response genes 
and secondary response genes. The requirement of chromatin remodeling is rooted in 
the CpG content of promoters. CpG-island promoters form unstable nucleosomes and 
are constitutively accessible, allowing for the rapid induction of many early primary 
response genes. Low CpG-island promoters form well-positioned nucleosomes that 
require chromatin remodeling, leading to delayed induction of late primary response 
genes and secondary response genes (Ramirez-Carrozzi et al., 2009).  
 
Although many systems genomic analyses have dissected and uncovered some 
common transcriptional regulation mechanisms, their statistical approach relies on a 
large sample size, which can potentially miss unique mechanisms that only regulate a 
few genes. Thus, we need to employ a different strategy to explore gene-specific 
regulatory mechanisms. In this dissertation, we used a gene-centric, stringent system 
approach that highlights the quantitative nature of genomic data. In chapter 2, we used 
this approach to dissect the TLR4 transcriptional cascades and classified lipid A-
induced genes by upstream signal pathways and transcription factors. We also explored 
the selective regulatory mechanisms by key transcription factors including NFκB and 
SRF. To understand the selective and combinatorial regulation of transcription factors, 
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we investigated a classical SRF-TCF combinatorial regulation model and identified motif 
rules governing the activity of SRF and TCF.  
 
Explore Gene-Specific Regulatory Mechanisms Using a Stringent Systems 
Approach  
Many systems approaches assume that one transcription factor or pathway can 
regulate hundreds of genes. In these cases, statistical methods can efficiently reveal 
common regulatory mechanisms, but they may also miss selective mechanisms that 
regulate only a few genes. To reveal gene-specific regulatory mechanisms, we 
improved the experimental design and applied a stringent systems approach. Our 
strategies showed at least four advantages in unveiling the gene-specific regulatory 
mechanisms.  
 
First, we measured the nascent transcript levels by isolating chromatin-associated RNA 
for RNA-seq analysis. This directly quantifies transcription rate and prevents the 
interference of mRNA stability. Second, we focused our analysis on strongly induced 
genes. Although key inflammatory genes are among the most strongly induced genes, 
strongly induced genes (fold change >10) only constitute 20% of all induced genes (fold 
change >2). Given that the strongly and weakly induced genes possess different 
transcriptional characteristics and are regulated by different mechanisms, separating 
strongly and weakly induced genes will prevent a biased conclusion towards the 
majority weakly induced genes. We can then apply the knowledge learned from strongly 
induced genes to studying weakly induced genes. Third, by focusing on strongly 
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induced genes, perturbation studies exhibited robust changes compared to control 
samples and gave us confidence to identify the targets regulated by different pathways 
and transcription factors. Last, we identified direct and functional protein binding events 
by combining the ChIP-seq and motif data. These data reveal that strong binding is 
highly correlated with strong motifs at the functional sites for two important transcription 
factors, NFκB and SRF.  
 
By quantitatively dissecting TLR4 transcriptional cascades using stringent criteria, we 
classified the strongly induced genes by their kinetics and regulatory mechanisms. This 
also discloses several gene-unique regulatory mechanisms. We found that NFκB and 
IRF3 can selectively and collaboratively regulate five lipid A-induced genes through 
promoter binding. These five genes include Ifnb1 and Ccl5. Interestingly, Ifnb1 and Ccl5 
promoters use different strategies for NFκB and IRF3 interaction. While Ifnb1 promoter 
is accessible before the cooperative binding of NFκB and IRF3, Ccl5 promoter requires 
chromatin remodeling by IRF3 before NFκB binding. Another three NFκB/IRF3 genes 
also require strong remodeling at the promoter, but they probably depend on another 
factor CEBPβ. The differential regulation by NFκB and IRF3 demonstrates that critical 
inflammatory genes can achieve selective regulation by combining transcription factor 
binding, DNA context, and chromatin regulation.  
 
Identify Rules Regulating the Functional Binding of SRF in a Lipid A Response  
Besides five selective NFκB/IRF3 genes, we also found another small subset of genes 
selectively regulated by SRF. Although SRF binds to hundreds of promoters and 
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enhancers in the genome, only a small number of SRF targets were activated by lipid A. 
To understand the selective regulatory mechanisms of SRF targets, many studies used 
a peak-centric method. It first proposed the putative functional peaks and then tested 
them by statistical correlation with expression data. This method often lacks precision to 
understand the mechanistic details of complicated transcription events. To find the 
precise mechanisms regulating transcription, we employed a gene-centric method. We 
examined the shared characteristics and common patterns of SRF targets and identified 
rules that can explain the functional binding events.  
 
By comparing the promoter SRF motifs of SRF targets, we found that functional SRF 
binding sites share a strict SRF-TCF cassette. This SRF-TCF cassette is rare; only 
another nine promoters in the mouse genome contain it, but they are inaccessible and 
thus are not inducible by lipid A. The characterized SRF-TCF cassette could also 
possibly explain the potent SRF binding at promoters of many SRF targets. We found 
that the SRF cofactor, TCF, can enhance SRF binding by forming a ternary complex. 
Ternary complex formation is required for the optimal H3K4me3 marking and 
transcriptional activation. Interestingly, SRF-TCF motifs also exist at enhancers that 
have exceptionally strong SRF binding near SRF targets. Thus, by studying the 
common motif features of SRF targets, we found that the selective activation of SRF 
targets require the combinatorial regulation of SRF and TCF. Because their SRF-TCF 
cassettes reside in CpG-island promoters, which are constitutively accessible, these 
SRF targets are also inducible in other cell types and are sensitive to different TCF 
activators. Given that most SRF targets regulate essential cellular functions including 
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cell growth, proliferation, and apoptosis, the selective regulation by SRF and TCF 
ensures these key genes can faithfully respond to various environmental stimuli in 
different cell contexts.  
 
Implications and Future Directions 
The analyses in this dissertation demonstrate our initial efforts to surface the 
mechanisms underlying the complicated transcriptional cascades in the innate immune 
response. They also provide many interesting observations that warrant further 
investigation. One frequent observation common for many transcription factors is the 
skewed distribution of ChIP-seq peak score (Figure 4-1). It is interesting that the peak 
score distribution does not exhibit a normal distribution. Normal distribution is common 
for many other biological features including the cell size, body height, and blood 
pressure (Marshall et al., 2012; A’HEARN et al., 2009; Wright et al., 2011). These 
biological features are tightly regulated by many factors within a narrow range. The 
stringent regulation will exclude any individual that falls out of the optimal range, 
resulting in a relatively homogeneous population close to an optimal value. On the other 
hand, the skewed distribution is more frequently seen in phenomena in social sciences 
such as the distribution of wealth (Berman et al., 2016; Bassani et al., 2014). In these 
cases, the population is rather heterogeneous; a small subset of extremely strong 
events dramatically differs from the majority of weak events. The sum of this small 
percent of extreme events usually has greater effects than the sum of all weak events.  
 
The skewed distribution of ChIP-seq peak score implies that the transcription factor 
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binding in vivo might follow a different regulatory mechanism from other biological 
features that results in homogenous populations. The homogenous populations with 
normal distribution may result from factors excluding abnormal individuals beyond the 
optimal range by affecting their essential functions. The heterogeneous population of 
ChIP-seq peaks implies that non-functional binding in vivo does not adversely affect key 
cellular functions, and thus are not excluded by evolution. The prevalent redundant 
“non-functional” binding sites may prepare the cells to evolve new functional cis-
regulatory elements in an ever-changing environment. But it is also likely the non-
functional binding is a consequence of technical artifacts. Because the functional sites 
are relatively few (for example, only 8 of 166 SRF promoter peaks contribute to a lipid A 
response) in many contexts, studying all sites together will lead to biased conclusions 
that overshadow the regulatory mechanisms of functional sites. Thus, it is essential to 
separate the functional and non-functional sites using stimulus-specific criteria.  
 
Many studies have endeavored to find a universal strategy to identify functional ChIP-
seq peaks. Some studies defined functional sites with the strongest peaks, which are 
called “super enhancers.” They are usually much stronger or wider peaks than normal 
enhancers (Pott and Lieb, 2015; Whyte et al., 2013; Hnisz et al., 2013). Consistently, 
most of our functional SRF peaks rank among the strongest peaks. However, not all 
strong peaks are functional in a certain context. Some peaks may be active in one 
context, but not in another. It is tempting to hypothesize that peaks frequently activated 
by various environmental stimuli during evolution are more important, so they are more 
likely to be conserved and become stronger than other less important peaks. Thus, the 
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strong peaks may be more likely to represent functionally important sites during the 
evolution, which are often selective to different contexts or stimuli. But the context-
specific regulatory mechanisms are largely unknown. The statistical methods often 
require large sample sizes and can potentially ignore the relatively few number of 
context-specific peaks. By identifying the patterns of lipid A-specific targets, we can 
avoid the limitation of statistics and identify rules that selectively activate important 
transcription factors. Although in this dissertation, we have identified motif requirements 
as a critical factor that distinguishes the functional sites of SRF in a lipid A response, we 
cannot exclude the possibility that other factors can also contribute to the functional 
binding and transcriptional activation. Other mechanisms might include motif location, 
chromatin state, and histone marks. Future studies can address the possibility of other 
mechanisms by studying the selective transcriptional regulation under different stimuli 
and in different cell types.  
 
We focused our analyses on promoters because they are better characterized than 
enhancers. In future studies, we will extend our analysis to enhancers, which might 
require different regulatory mechanisms from promoters. Our CRISPR mutation 
experiments on Egr3 revealed that both the enhancer and the promoter are essential for 
Egr3 gene induction. This implies that the optimal induction of Egr3 requires the 
collaboration of the enhancer and promoter through promoter-enhancer interaction. The 
step-wise mechanism of this induction remains unclear. We can try to understand the 
promoter-enhancer interaction by HiC and mutation experiments. Although we still lack 
the knowledge to identify the targets of enhancers, we can get initial insights from the 
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regulatory mechanisms of individual enhancers like the Egr3 enhancer and extend our 
insights to broader studies. Understanding transcription factor regulation at enhancers 
will also allow for a better characterization of enhancers.  
 
Although we have demonstrated that some transcription factors can activate 
transcription by altering chromatin features, it is still unclear how transcription factor 
binding leads to chromatin changes. In our studies, we find that IRF3 binding to the Ccl5 
promoter precedes SWI/SNF binding, chromatin remodeling, NFκB binding, and 
transcriptional induction. It is still unclear how IRF3 binds to an inaccessible region and 
initiates remodeling. It is very likely that it binds at the edge of a well-position 
nucleosome or on a small accessible window of the nucleosome. We need further 
investigation into the stepwise mechanistic details of this process in future studies. 
Intriguingly, IRF3 can also bind to accessible promoters that do not require chromatin 
remodeling. It will be interesting to understand whether IRF3 can detect chromatin 
contexts to apply different regulatory mechanisms. To understand the roles of IRF3 in 
initiating chromatin remodeling, we can also compare it with other transcription factors 
that can also induce chromatin remodeling, particularly transcription factors in the IRF 
family.  
 
Besides combinatorial regulation, many other mechanisms could potentially contribute 
to selective transcriptional induction. One mechanism involves the selective binding of 
different transcription factor members that have slightly different motif preference. For 
example, NFκB family transcription factors can recognize and bind ubiquitously to many 
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canonical NFκB sites. However, the Il12b promoter contains a non-canonical NFκB site, 
which is highly selective for c-Rel. This preference leads to selective inhibition of Il12b in 
c-Rel knockout cells without affecting other NFκB targets (Sanjabi et al., 2005). Similar 
preference for a certain transcription factor member might also exist in other 
transcription families. For example, AP1 family transcription factors consist of Fos 
proteins and Jun proteins. Different combinations of Fos and Jun dimers can result in 
different binding preference (Mechta-Grigoriou et al., 2001; Karin et al., 1997).  
 
Another possible selective regulatory mechanism is the use of alternative cofactors. For 
example, SRF activity requires two competing cofactors: MRTF transcription factors and 
TCF transcription factors. While TCF family members can form ternary complexes with 
SRF and activate genes regulating cell proliferation, apoptosis, and circadian clock, 
MRTF family members can bind to SRF and activate cytoskeletal genes. One member 
of the MRTF family, myocardin, is selectively expressed in muscle cells and regulates 
muscle-specific genes (Olson and Nordheim, 2010; Posern and Treisman, 2006;). 
Another example is CREB, which can interact with two cofactors: CBP and CRTC2 
(Altarejos and Montminy, 2011; Mayr and Montminy, 2001). While the CBP-CREB 
interaction controls genes regulating broad functions, CRTC2-CREB can selectively 
activate genes regulating metabolic functions.  
 
To get a more comprehensive understanding of mechanisms regulating lipid A 
transcriptional cascades, we can use our stringent systems approach to examine the 
binding profiles of other transcription factors. Besides NFκB, IRF3, and SRF, many 
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other transcription factors also contribute to the lipid A response, which include CEBP, 
AP1, and CREB. We can explore the ChIP-seq data from these factors with respect to 
three aspects.  
 
First, we can dissect their binding profiles using our gene-centric approach and 
investigate the mechanisms that activate lipid A-responsive sites. Second, lipid A can 
induce different transcription factor members in the same family. It will be interesting to 
compare the common and unique properties of different transcription factor members. 
By comparing their kinetics, peak strength, motifs, and other characteristics, we can 
uncover the selective mechanisms underlying the redundant and differential use of 
transcription factor members. Furthermore, we can integrate transcription factor binding 
properties with other features including chromatin accessibility and histone mark data. 
The potential coordination of chromatin regulation and transcription factor will illuminate 
on the complexity of transcription factor regulation in the native environment. Third, 
several transcription factors often act in concert to induce transcription. After 
understanding how each transcription factor functions individually, we can then explore 
their combinatorial regulation. For example, besides NFκB and IRF3, CEBPβ also binds 
to the promoters of three NFκB/IRF3 genes. These three NFκB/IRF3 genes undergo 
chromatin remodeling before NFκB and IRF3 binding. It is likely that CEBPβ binds at 
these three NFκB/IRF3 genes to initiate chromatin remodeling, which permits NFκB and 
IRF3 binding and gene induction. Taking advantage of the well-defined lipid A-induced 
gene classes, we can investigate more selective mechanisms by combination of 
transcription factors. Eventually, by clarifying the roles of different transcription factors, 
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we can refine the classification of lipid A-induced genes. This will enable us to evaluate 
the contribution of key transcription factors during inflammation.  
 
There are also many challenges for analyzing ChIP-seq data from different transcription 
factor family members. Because transcription factor family members may share 
homologous domains, it may be technically challenging to find specific ChIP antibodies 
for each transcription factor member. Furthermore, there is often functional redundancy 
between different family members, so knockout of one gene might not uncover all 
targets. Mutating all transcription factor members is technically difficult and is often 
lethal. The difficulty to identify targets might compromise the identification of functional 
ChIP-seq peaks. If a transcription factor is selectively expressed in macrophages, there 
is an alternative approach. We can compare the gene expression in other cell types. If a 
gene is selectively activated only in macrophages, then it is more likely to be a real 
target.  
 
Taken together, by carefully dissecting the lipid A transcriptional cascades and 
uncovering selective regulatory mechanisms of transcription factors, we have 
demonstrated the efficacy and potential of mining the gene-specific regulatory 
mechanisms using our stringent systems approach. This approach will benefit future 
genomic studies and provides potential applications in medicine. With the emergence of 
cheaper personal sequencing technologies, it is likely that clinicians will adopt genomic 
analyses for personalized medicine in the future. By comparing the gene expression 
profiles of the control and patient samples, it is possible to make more accurate 
  150 
diagnoses and find better treatment options. However, inflammatory diseases often 
disrupt complicated gene networks involving both common and gene-specific regulatory 
mechanisms. Conventional systems approaches can detect large-scale expression 
changes regulated by common mechanisms, but our approach can also detect unique 
changes regulated by gene-specific mechanisms. The combination of both approaches 
will provide a precise diagnosis of complicated inflammatory diseases by identifying 
critical regulators in disease pathogenesis. Besides the applications in disease 
diagnosis, investigation of gene-specific mechanisms regulated by transcription factors, 
chromatin regulation, and other mechanisms will also facilitate the development of 
selective medications to treat human diseases with minimal side effects.  
 
 
 
Figure Legend 
Figure 4- 1 The Distribution of SRF and RelA ChIP-seq Peak Scores 
 (A) Line graph displays the peak score of 718 reproducible SRF ChIP-seq peaks 
identified by HOMER software. Peaks are ranked by peak strength. (B) Line graph 
displays the peak score of 8458 reproducible RelA ChIP-seq peaks identified by 
HOMER. Peaks are ranked by peak strength. 
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Figure 4-1 The Distribution of SRF and RelA ChIP-Seq Peak Score 
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